News on Chronic Myeloid Leukemia (CML)
Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells
May 24, 2012, Cell
May 24, 2012, Cell
Oryzon Nominates Specific LSD1 Inhibitor as Drug Candidate to Enter Preclinical Development in Acute Leukemia and Other Hematological Cancers
May 24, 2012, virtual-strategy
May 24, 2012, virtual-strategy
Ariad CEO says Italy and Spain likely to pay for new cancer drug
May 24, 2012, The Boston Globe
May 24, 2012, The Boston Globe
Chronic myeloid leukemia in children and adolescents: Results of treatment with imatinib mesylate.
May 18, 2012, PubLmed
May 18, 2012, PubLmed
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
May 18, 2012, Leukemia
May 18, 2012, Leukemia
Gleevec - $1.51 billion
May 15, 2012, Fierce Pharma
May 15, 2012, Fierce Pharma
5% Fund Ownership Filings In Healthcare: 2 Surging And 2 Plunging Stocks Bought And 5 Others
May 15, 2012, Seeking Alpha
May 15, 2012, Seeking Alpha
Protests in US over high pricing of Novartis' anti-cancer drug Glivec
May 15, 2012, The Economics Times
May 15, 2012, The Economics Times
Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At 2012 ASCO Annual Meeting
May 14, 2012, Enhanced Online News
May 14, 2012, Enhanced Online News
Commentary: Join me in the fight against blood cancers
May 11, 2012, Daily Pilot
May 11, 2012, Daily Pilot
Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)
May 10, 2012, 24/7 Wall
May 10, 2012, 24/7 Wall
Kristen Jordan Shamus: After tragedy, Westland woman finds life's purpose
May 6, 2012, Detroit Free Press
May 6, 2012, Detroit Free Press
Nilotinib superior to imatinib in older patients with CML in chronic phase
May 4, 2012, Oncology Nurse Advisor
May 4, 2012, Oncology Nurse Advisor
Hematopoietic Interferon Regulatory Factor 8-Deficiency Accelerates Atherosclerosis in Mice
May 3, 2012, Unbound Medline
May 3, 2012, Unbound Medline
Birmingham-based National CML Society Helps Patients With Challenges Of Devastating Illness
May 3, 2012, Birmingham Medical News
May 3, 2012, Birmingham Medical News
Bryan Baker Motivated by Family’s Future Ahead of Bellator 67 Clash with Ben Saunders
May 3, 2012,Sher Dog
May 3, 2012,Sher Dog
Cyclist hosts Race Across America film at Los Altos High as she preps for event
May 2, 2012, Los Altos Town Crier
May 2, 2012, Los Altos Town Crier
A novel five-way translocation t(7;11;9;22;9)(q22;q13;q34;q11.2;q34) involving Ph chromosome in a tient of chronic myeloid leukemia:
May 1, 2012, 7th space
May 1, 2012, 7th space
Airmen shed blood for a cause in celebration of Philippine Air Force 65th anniversary
May 1, 2012, Philippine Information Agency
May 1, 2012, Philippine Information Agency
Front-Line Therapy for CML (diaporama)
April 2012, First Middle East Hematology forum
April 2012, First Middle East Hematology forum
Novartis and US Representatives in Congress: Reduce to patients the cost of the drug, Gleevec. (Petition)
April 27, 2012, change.org
April 27, 2012, change.org
Firefighters Spotlight Need for Asian-American Bone
Marrow Donors
April 27, 2012, Rancho Bernardo Patch
Marrow Donors
April 27, 2012, Rancho Bernardo Patch
Early landmark analysis of imatinib treatment in CML chronic phase: Less than 10% BCR-ABLby FISH at 3 months associated with improved long-term clinical outcome
April 26, 2012, Wiley Online Library
April 26, 2012, Wiley Online Library
Incyte Reports 2012 First-Quarter Financial Results; Updates Shareholders on Commercial Activity and Key Clinical Programs
April 26, 2012, Market Watch
April 26, 2012, Market Watch
Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy
April 24, 2012, Haematologica
April 24, 2012, Haematologica
AACR 2012: Promising CML & PI3K compounds from Indian company Piramal Healthcare (P2745 - T315i mutation)
April 24, 2012, Biotech Strategy Blog
April 24, 2012, Biotech Strategy Blog
Pharmaceuticals and Alcon performed strongly in the first quarter; overall Group results impacted by expected challenges
April 24, 2012, Reuters
April 24, 2012, Reuters
Novartis posts sharp drop in 1st-qtr profit; challenges UK off-label Avastin use
April 24, 2012, Pharma Letter
April 24, 2012, Pharma Letter
Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey
April 24, 2012, 7th Space Interactive
April 24, 2012, 7th Space Interactive
ASH Agenda for Hematology Research Identifies Most Promising
Areas for Scientific Discovery
April 24, 2012, Market Watch
Areas for Scientific Discovery
April 24, 2012, Market Watch
CBRE's Tom Cleaver goes after Leukemia and Lymphoma Society's Man of the Year award
April, 20. 2012, Washington Business Journal
April, 20. 2012, Washington Business Journal
BUDGET 2012: Province to provide free cancer drugs for all patients
April 19, 2012, Cancer Care Manitoba
April 19, 2012, Cancer Care Manitoba
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy.
April 19, 2012, PubLMed
April 19, 2012, PubLMed
Update in Hematology and Medical Oncology: Evidence Published in 2011
April 18, 2012, Annals of Internal Medecine
April 18, 2012, Annals of Internal Medecine
Wayward gene found, vanquished in some East Asians with CML and NSCLC
April 18, 2012, Oncology Nurse Advisor
April 18, 2012, Oncology Nurse Advisor
Piramal Healthcare presents data on its investigational drug candidates at AACR
April 17, 2012, Express Pharma
April 17, 2012, Express Pharma
City of Hope researchers show how cancerous stem cells manipulate their environment to enhance their own growth in chronic myelogenous leukemia
April 16, 2012, City of Hope
April 16, 2012, City of Hope
Pharmaceutical testing by zebrafish molecular screening yields lendaldekar for leukemia
April 14, 2012, dailyRX
April 14, 2012, dailyRX
The sun rises again at the annual CML Patient Advocates Meeting for Asia Pacific advocates
April 13, 2012, The Max Foundation
April 13, 2012, The Max Foundation
Leukemia & Lymphoma Society Facts
April 13, 2012, The Rush Limbaugh
April 13, 2012, The Rush Limbaugh
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure.
April 12, 2012, PublMed
April 12, 2012, PublMed
Novel Compound Demonstrates Anti-Leukemic Effect in Zebrafish, Shows Promise for Human Treatment
April 9, 2012, ScienceDaily
April 9, 2012, ScienceDaily
Novel Compound Demonstrates Anti-Leukemic Effect in Zebrafish, Shows Promise for Human Treatment
April 9, 2012,PRNewswire
April 9, 2012,PRNewswire
Stemming the Return of Leukemia – CML may be stopped with combo therapy (β-catenin inhibitors)
April 7, 2012, DailyRx
April 7, 2012, DailyRx
Son's leukemia sends mom on search for donor
April 7, 2012, SFGate
April 7, 2012, SFGate
Study Points the Way for Future Therapy to Revive a Damaged Immune System
April 6, 2012, Memorial Sloan-Kettering Cancer Center
April 6, 2012, Memorial Sloan-Kettering Cancer Center
Novartis launches the Cancer Cell Line Encyclopedia to catalog world's cancer cell lines
April 4, 2012, Bio-Medicine.
April 4, 2012, Bio-Medicine.
Piramal to present data on its three IND candidates at AACR annual meeting in Chicago
April 4, 2012, Pharmabiz.com
April 4, 2012, Pharmabiz.com
Novel potent inhibitor (P2745 ) of Bcr-Abl mutated imatinib resistant chronic myeloid leukemia cell lines (included
T315I)
April 2, 2012, AACR Annual Meeting 2012
T315I)
April 2, 2012, AACR Annual Meeting 2012
Research and Markets: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2012
April 2, 2012, Business Wire
April 2, 2012, Business Wire
First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia
March 30, 2012, Leukemia
March 30, 2012, Leukemia
Pulling together to help C.J.
March 30, 2012, Petaluma360.com
Petrov diagnosed with acute leukaemia
March 30, 2012, Foxsports
March 30, 2012, Petaluma360.com
Petrov diagnosed with acute leukaemia
March 30, 2012, Foxsports
A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line
March 30, 2012, 7th Space
Fighting cancer on the home front
March 30, 2012, IrishTimes.com
March 30, 2012, 7th Space
Fighting cancer on the home front
March 30, 2012, IrishTimes.com
New inhibitors of a cancer-causing protein may lead to targeted therapeutics
March 29, 2012, Physorg.com
March 29, 2012, Physorg.com
Despite Significant Advances in the Treatment of Chronic Myeloid Leukemia (CML) Over the Last Decade, Hematologist-Oncologists Report High Unmet Need for New Therapies in TKI Treatment-Resistant Patients
March 29, 2012, Market Watch
March 29, 2012, Market Watch
NIH scientists resolve how chromosomal mix-ups lead to tumors
March 28, 2012, PharmPro
Myeloid Malignancies Underreported In U.S
March 28, 2012, Newswise
March 28, 2012, PharmPro
Myeloid Malignancies Underreported In U.S
March 28, 2012, Newswise
Fighter
pilot donates bone marrow
March 28, 2012, The Korea Herald
One in a Million – Children with CML
March 28, 2012, Petaluma Patch
Study in JAMA reports significant survival benefit in certain GIST patients taking Novartis drug GlivecR for three years after surgery
March 27, 2012,Reuter
March 28, 2012, The Korea Herald
One in a Million – Children with CML
March 28, 2012, Petaluma Patch
Study in JAMA reports significant survival benefit in certain GIST patients taking Novartis drug GlivecR for three years after surgery
March 27, 2012,Reuter
It’s In The Genes: East Asians More Likely To Be Resistant To Some Cancer Drugs
March 21, 2012, Asian Scientist
March 21, 2012, Asian Scientist
Envita Medical Centers cancer treatment
March 20, 2012, abc15.com
‘We want a world without blood cancer,’ Bowie survivors say
March 20, 2012, Gazette.net
March 20, 2012, abc15.com
‘We want a world without blood cancer,’ Bowie survivors say
March 20, 2012, Gazette.net
For the Treatment of Refractory Chronic Myeloid Leukemia, Interviewed Thought Leaders Indicate That Ponatinib Has Efficacy Advantages over Sprycel, the Sales Leading Agent in the United States
March 19, 2012, Market Watch
March 19, 2012, Market Watch
Genetic Variation in East Asians Found to Explain Resistance to Cancer Drugs
March 18, 2012, Science Daily
Ohio legislator wants insurance coverage to be same for oral, injectable chemotherapy treatments
March 17, 2012, Cleveland.com
The Reactivity of the Cellular Transcriptome to Xenobiotic Compound Perturbation
March 16, 2012, The New York Academy of Sciences
Inovio Pharmaceuticals Reports 2011 Fourth Quarter and Year-End Financial Results
March 15, 2012,Bradenton.com
AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board
March 15, 2012, Market Watch
March 18, 2012, Science Daily
Ohio legislator wants insurance coverage to be same for oral, injectable chemotherapy treatments
March 17, 2012, Cleveland.com
The Reactivity of the Cellular Transcriptome to Xenobiotic Compound Perturbation
March 16, 2012, The New York Academy of Sciences
Inovio Pharmaceuticals Reports 2011 Fourth Quarter and Year-End Financial Results
March 15, 2012,Bradenton.com
AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board
March 15, 2012, Market Watch
Postal worker saves life of British cancer patient VIDEO
March 15, 2012, msnbc.com
Indian Supreme Court to Rule on Gleevec Patent
March 12, 2012, Patent Docs
Lisa Velasco: Managing CML With A Husband's Strong Support VIDEO
March 11, 2012, Patient Power
March 15, 2012, msnbc.com
Indian Supreme Court to Rule on Gleevec Patent
March 12, 2012, Patent Docs
Lisa Velasco: Managing CML With A Husband's Strong Support VIDEO
March 11, 2012, Patient Power
Del Norte students trying to raise $10,000 to fight cancer
March 10, 2012, Pomerado News
Pfizer Looks Set To Dominate With Takeovers
March 9, 2012, Seeking Alpha
Insights into early child hood leukemia - Early T cell precursor acute lymphoblastic leukemia has myeloid aspects
March 8, 2012, daily RX
Imatinib helpful after interferon fails in CML treatment
March 8, 2012, OncologyNurseAdvisor
Pain is more Painful in Poor Place - Chronic pain tougher to manage for young patients
Mar 6, 2012, Daily Rx
India’s Supreme Court to Hear Dispute on Drug Patents
March 6, 2012, The New York Times
Possible bone marrow match for firefighter
March 5, 2012, U-T News San Diego
Ariad Pharmaceuticals - Much to live up to
March 5, 2012, Edison Investment Research
A local university student has become the 3,000th bone marrow donor in South Korea.
March 4, 2012, The Korea Herald
I won my cancer battle thanks to wonder drug
March 2, 2012, Weekly News
Cancer drugs to help halt Ebola virus
March 2, 2012, PakTibune
Leukemia drugs found effective limiting Ebola
March 1, 2012, The Vancouver Sun
Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia
February 29, 2012, BioInfobank Librairy
Myelofibrosis Drug Shrinks Symptoms
February 29, 2012, Medpage Today
Cancer: Solving an age-old problem
February 29, 2012, Nature
Rare disease day – 29 February 2012
February 29, 2012, rarediseaseday.org
Leukemia Survival Up with Gleevec
February 29, 2012, MedPage Today
Cancer drugs could halt Ebola virus
February 29, 2012, MSN News
Blood ambassadors
February 29, 2012, Goulburn Post
Drug Helps Leukemia Patients Live Longer
February 29, 2012, Ivanhoe
ARIAD Reports 2011 Financial Results and Outlines Key Development and Commercialization Plans for 2012
February 28, 2012, Market Watc
Ten-Year CML Survival Estimate of 68 Percent With Imatinib
February 28, 2012, OncologyNurseAdvisor
EU approves new label for Novartis drug Glivec extending adjuvant therapy to 3-years for certain GIST patients
February 28, 2012, Pharmabiz.com
Imatinib Effective in CML Patients Who Failed Interferon
February 27, 2012, Medscape Today
Dr. Erba Describes Proper Diagnostic Testing of CML VIDEO
February 27, 2012, Onc Live
Managing Chronic Myeloid Leukemia Treatment
February 27, 2012, Onc Live
Ten-Year CML Survival Estimate of 68 Percent With Imatinib
February 27, 2012, DoctorsLounge
CML patients can benefit from imatinib after unsuccessful interferon therapies
February 27, 2012, News-Medical.net
Novartis' Glivec extends European GIST licence
February 27, 2012, PMLiVE
Novartis explains stance over India patent law challenge
February 27, 2012, Pharma Times Online
GOING?TO?THE?TOP
February 27, 2012, Sun-Gazette
Blocking the Blockers – CML stem cell enzyme may become new target
February 26, 2012, Daily RX
Cutting-edge research dulled by lack of funding
February 26, 2012, DentonRc.com
Exploring Disease Risk and Treatment Options for CML VIDEO
February 24, 2012, Patient Power
Dr. Liu makes the case for genomics and personalized medicine
February 24, 2012, The CT mirror
Novartis again urged to drop India patent lawsuit
February 24, 2012, PharmaTimes Online
Montrealer looking for a bone marrow hero
February 23, 2012, CTV.ca
Protest against Novartis' Indian lawsuit on Glivec
February 23, 2012, AFP
New heart drug will get government subsidy
February 21, 2012, The Australian
Hopes high for dandelion root trials in Windsor
February 20, 2012, The Windsor Star
Gleevec reformulated eliminates morphine tolerance in animal study
February 20, 2012, dailyRx
Ont. researchers probe use of dandelion root on cancer cells
February 19, 2012, Nanaimo Daily News
John Mailes freed from death sentence
February 19, 2012, Herald Sun
New Lawsuit Filed on Benzene Leukemia: AttorneyOne.com Provides Advice and Solutions for the ongoing Threat
of Leukemia from Benzene
February 17, 2012, Timesunion.com
New Lawsuit Filed on Benzene Leukemia: AttorneyOne.com Provides Advice and Solutions for the ongoing Threat
of Leukemia from Benzene
February 17, 2012, PRWeb
ELN Recommendations - Patient-friendly summary in seven languages
February 17, 2012, CML Advocates Network
Can dandelions kill cancer?
February 16, 2012, Global Edmonton
Stephens v. Skanska USA Bldg., INC.
February 16, 2012, LEAGLE
Bone Marrow Drive Held For Local Firefighter
February 16, 2012, News.com
Nilotinib Continues To Produce Deep Response in Patients
February 2012, Clinical Oncology
Francis Collins: 3 Scientific Breakthroughs Changing Medicine VIDEO
February 15, 2012, Medscape
Incyte Reports 2011 Fourth-Quarter and Full-Year Financial Results;
Provides 2012 Financial Guidance; Updates Shareholders on Key Clinical Programs
February 15, 2012, Eon
A global attack on cancer
February 15, 2012, The Londoner
Ariad wins key patent for leukemia drug
February 15, 2012, The Boston Globe
Incyte Reports 2011 Fourth-Quarter and Full-Year Financial Results; Provides 2012 Financial Guidance; Updates Shareholders on Key Clinical Programs
February 15, 2012, MarketWatch
Hematologic Cancers in Pregnancy Pose Substantial Risks
February 14, 2012, Medscape
Bone marrow drive for San Diego firefighter
February 14, 2012, UT San Diego
Seattle's Sage Bionetworks seeks a drug-discovery revolution
February 13, 2012, The Seattle Times
Looming shortage of cancer drugs causing concern for many
February 13, 2012, WHPTV.com
Ariad's stock jumps on drug sales projection
February 13, 2012, Boston Business Journal
Therapy targets leukemia stem cells
February 13, 2012, Eurekalert
A man's need sparks bone marrow donor drive
February 11, 2011, Fort Dodge Messenger
All You Can Eat Pasta Dinner/Fundraiser for Cancer Charity
February 11, 2012, windsoriteDOTca
In-vivo proof of concept in malignant melanoma
February 9, 2012, Reuters
Outwitting Chronic Myeloid Leukemia
February 9, 2012, DailyRx
Can The Man From Heinz Keep Novartis On Top?
February 8, 2012, Forbes
Bio-Path completes second cohort dosing of leukemia drug trial
February 8 , 2012, Pharmaceutical Business Review
Blood cancer fundraiser scheduled for Friday
February 8, 2012, Easter& Associates
Ambit Biosciences Appoints Athena Countouriotis as Chief Medical Officer
February 8, 2012, The Sacramento Bee
Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor Optimization and Selectivity Trial
February 7, 2012, Haematologica
Local men join NEPA firefighters in charity building climb
February 7, 2012, Thedailyreview.com
Gleevec wins wider approval for use in GI cancer
February 7, 2012, OncologyNurseAdvisor
UPDATE: Governor urges community to support bone marrow drive
February 6, 2012, Guampdm.com
Fundraiser for leukemia research set
February 6, 2012, Observer Today
Med schemes can refuse to pay for super drugs
February 5 2012, Personal Finance
Cyclists to hold 511-km tour for leukemia
February 4, 2012, The Jakarta Post
Kareem: Back-to-basket centers gone
February 4, 2012, ESPN LA
Benzene Leukemia Lawsuit Filed Over Hazardous Workplace
February 3, 2012, Injuryboard
Funding the NIH: Investing in medical research is vital to our health
February 3, 2012, Oregon.Live
Gleevec indications expanded to include rare cancer
February 2, 2012, The Clinical Advisor
Sunesis Announces Appointment of Dr. Adam R. Craig as Chief Medical Officer
February 2, 2012, MarketWatch
Dreams still come true - Cancer survivor gives back to sick child through organization
February 1, 2012, The advocate
FDA Approves Label Change Recommending Three Years of Novartis' Glivec After GIST Surgery
February 1, 2012, GEN
March 10, 2012, Pomerado News
Pfizer Looks Set To Dominate With Takeovers
March 9, 2012, Seeking Alpha
Insights into early child hood leukemia - Early T cell precursor acute lymphoblastic leukemia has myeloid aspects
March 8, 2012, daily RX
Imatinib helpful after interferon fails in CML treatment
March 8, 2012, OncologyNurseAdvisor
Pain is more Painful in Poor Place - Chronic pain tougher to manage for young patients
Mar 6, 2012, Daily Rx
India’s Supreme Court to Hear Dispute on Drug Patents
March 6, 2012, The New York Times
Possible bone marrow match for firefighter
March 5, 2012, U-T News San Diego
Ariad Pharmaceuticals - Much to live up to
March 5, 2012, Edison Investment Research
A local university student has become the 3,000th bone marrow donor in South Korea.
March 4, 2012, The Korea Herald
I won my cancer battle thanks to wonder drug
March 2, 2012, Weekly News
Cancer drugs to help halt Ebola virus
March 2, 2012, PakTibune
Leukemia drugs found effective limiting Ebola
March 1, 2012, The Vancouver Sun
Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia
February 29, 2012, BioInfobank Librairy
Myelofibrosis Drug Shrinks Symptoms
February 29, 2012, Medpage Today
Cancer: Solving an age-old problem
February 29, 2012, Nature
Rare disease day – 29 February 2012
February 29, 2012, rarediseaseday.org
Leukemia Survival Up with Gleevec
February 29, 2012, MedPage Today
Cancer drugs could halt Ebola virus
February 29, 2012, MSN News
Blood ambassadors
February 29, 2012, Goulburn Post
Drug Helps Leukemia Patients Live Longer
February 29, 2012, Ivanhoe
ARIAD Reports 2011 Financial Results and Outlines Key Development and Commercialization Plans for 2012
February 28, 2012, Market Watc
Ten-Year CML Survival Estimate of 68 Percent With Imatinib
February 28, 2012, OncologyNurseAdvisor
EU approves new label for Novartis drug Glivec extending adjuvant therapy to 3-years for certain GIST patients
February 28, 2012, Pharmabiz.com
Imatinib Effective in CML Patients Who Failed Interferon
February 27, 2012, Medscape Today
Dr. Erba Describes Proper Diagnostic Testing of CML VIDEO
February 27, 2012, Onc Live
Managing Chronic Myeloid Leukemia Treatment
February 27, 2012, Onc Live
Ten-Year CML Survival Estimate of 68 Percent With Imatinib
February 27, 2012, DoctorsLounge
CML patients can benefit from imatinib after unsuccessful interferon therapies
February 27, 2012, News-Medical.net
Novartis' Glivec extends European GIST licence
February 27, 2012, PMLiVE
Novartis explains stance over India patent law challenge
February 27, 2012, Pharma Times Online
GOING?TO?THE?TOP
February 27, 2012, Sun-Gazette
Blocking the Blockers – CML stem cell enzyme may become new target
February 26, 2012, Daily RX
Cutting-edge research dulled by lack of funding
February 26, 2012, DentonRc.com
Exploring Disease Risk and Treatment Options for CML VIDEO
February 24, 2012, Patient Power
Dr. Liu makes the case for genomics and personalized medicine
February 24, 2012, The CT mirror
Novartis again urged to drop India patent lawsuit
February 24, 2012, PharmaTimes Online
Montrealer looking for a bone marrow hero
February 23, 2012, CTV.ca
Protest against Novartis' Indian lawsuit on Glivec
February 23, 2012, AFP
New heart drug will get government subsidy
February 21, 2012, The Australian
Hopes high for dandelion root trials in Windsor
February 20, 2012, The Windsor Star
Gleevec reformulated eliminates morphine tolerance in animal study
February 20, 2012, dailyRx
Ont. researchers probe use of dandelion root on cancer cells
February 19, 2012, Nanaimo Daily News
John Mailes freed from death sentence
February 19, 2012, Herald Sun
New Lawsuit Filed on Benzene Leukemia: AttorneyOne.com Provides Advice and Solutions for the ongoing Threat
of Leukemia from Benzene
February 17, 2012, Timesunion.com
New Lawsuit Filed on Benzene Leukemia: AttorneyOne.com Provides Advice and Solutions for the ongoing Threat
of Leukemia from Benzene
February 17, 2012, PRWeb
ELN Recommendations - Patient-friendly summary in seven languages
February 17, 2012, CML Advocates Network
Can dandelions kill cancer?
February 16, 2012, Global Edmonton
Stephens v. Skanska USA Bldg., INC.
February 16, 2012, LEAGLE
Bone Marrow Drive Held For Local Firefighter
February 16, 2012, News.com
Nilotinib Continues To Produce Deep Response in Patients
February 2012, Clinical Oncology
Francis Collins: 3 Scientific Breakthroughs Changing Medicine VIDEO
February 15, 2012, Medscape
Incyte Reports 2011 Fourth-Quarter and Full-Year Financial Results;
Provides 2012 Financial Guidance; Updates Shareholders on Key Clinical Programs
February 15, 2012, Eon
A global attack on cancer
February 15, 2012, The Londoner
Ariad wins key patent for leukemia drug
February 15, 2012, The Boston Globe
Incyte Reports 2011 Fourth-Quarter and Full-Year Financial Results; Provides 2012 Financial Guidance; Updates Shareholders on Key Clinical Programs
February 15, 2012, MarketWatch
Hematologic Cancers in Pregnancy Pose Substantial Risks
February 14, 2012, Medscape
Bone marrow drive for San Diego firefighter
February 14, 2012, UT San Diego
Seattle's Sage Bionetworks seeks a drug-discovery revolution
February 13, 2012, The Seattle Times
Looming shortage of cancer drugs causing concern for many
February 13, 2012, WHPTV.com
Ariad's stock jumps on drug sales projection
February 13, 2012, Boston Business Journal
Therapy targets leukemia stem cells
February 13, 2012, Eurekalert
A man's need sparks bone marrow donor drive
February 11, 2011, Fort Dodge Messenger
All You Can Eat Pasta Dinner/Fundraiser for Cancer Charity
February 11, 2012, windsoriteDOTca
In-vivo proof of concept in malignant melanoma
February 9, 2012, Reuters
Outwitting Chronic Myeloid Leukemia
February 9, 2012, DailyRx
Can The Man From Heinz Keep Novartis On Top?
February 8, 2012, Forbes
Bio-Path completes second cohort dosing of leukemia drug trial
February 8 , 2012, Pharmaceutical Business Review
Blood cancer fundraiser scheduled for Friday
February 8, 2012, Easter& Associates
Ambit Biosciences Appoints Athena Countouriotis as Chief Medical Officer
February 8, 2012, The Sacramento Bee
Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor Optimization and Selectivity Trial
February 7, 2012, Haematologica
Local men join NEPA firefighters in charity building climb
February 7, 2012, Thedailyreview.com
Gleevec wins wider approval for use in GI cancer
February 7, 2012, OncologyNurseAdvisor
UPDATE: Governor urges community to support bone marrow drive
February 6, 2012, Guampdm.com
Fundraiser for leukemia research set
February 6, 2012, Observer Today
Med schemes can refuse to pay for super drugs
February 5 2012, Personal Finance
Cyclists to hold 511-km tour for leukemia
February 4, 2012, The Jakarta Post
Kareem: Back-to-basket centers gone
February 4, 2012, ESPN LA
Benzene Leukemia Lawsuit Filed Over Hazardous Workplace
February 3, 2012, Injuryboard
Funding the NIH: Investing in medical research is vital to our health
February 3, 2012, Oregon.Live
Gleevec indications expanded to include rare cancer
February 2, 2012, The Clinical Advisor
Sunesis Announces Appointment of Dr. Adam R. Craig as Chief Medical Officer
February 2, 2012, MarketWatch
Dreams still come true - Cancer survivor gives back to sick child through organization
February 1, 2012, The advocate
FDA Approves Label Change Recommending Three Years of Novartis' Glivec After GIST Surgery
February 1, 2012, GEN
FDA Approves Gleevec For Expanded Use in Patients With Rare Gastrointestinal Cancer
January 31, 2012, MarketWatch
2 Potentially Solid Transdermal Drug Biotechs With Catalysts For 2012
January 31, 2012,Seeking Alpha
Bonney Lake to Host Relay for Life, Mayor Neil Johnson Selected as Guest Speaker
January 30, 2012, Bonney Lake-Sumner Patch
Tasigna Recommended as Second-line CML Therapy - Tasigna receives final recommendation from NICE
January 30, 2012, DailyRx
FDA accepts NDA for Pfizer CML drug
January 30, 2012, Pharmaceutical Business Review
Candid Cancer segment - what to know about getting a second opinion. VIDEO
January 29, 2012, A wider world
Area medical centers provide improvements to cancer treatments
January 28, 2012, greenbaypressgazette.com
CML Update at ASH 2011 - Interview with Elias Jabbour, M.D. VIDEO
January 27, 2012, OncUViewTV
FDA accepts Pfizer leukemia treatment for review
January 27, 2012, CBS Money Watch
Earnings Preview: Pfizer to report on 4th quarter
January 27, 2012, CBS Money Watch
Relentless for a Cure
January 26, 2012, Leukemia & Lymphoma Society
True Chronic Myeloid Leukemia Specific Antigen Vaccines
January 26, 2012, Johnny Silva Cancer Research
Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ CML
January 26, 2012, Pfizer
For CML, Nilotinib Superior to Imatinib at 24 Months
January 26, 2012, Clinical Oncology
Bristol-Myers Misses Analyst Estimates as Costs Increase to Gain New Drugs
January 26, 2012, Bloomberg
BB Biotech closes 2011 with a positive performance and confirms upward trend
January 26 ,2012, Reuters
Understanding Molecular Response with Respect to Cure VIDEO
January 25, 2012, Patient Power
Bill introduced to allow cancer patients access to easier, more affordable chemo
January 25, 2012, WGMD.com
Novartis Drugs Backed by CHMP
January 25 ,2012, Zacks.com
Kareem Abdul-Jabbar – In His Own Words
January 25, 2012, Coping with cancer
Leukemia Drug and Magnet Material Net Japan Prizes
January 25, 2012, Science Insider
HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells
January 24, 2012, Journal Blood
Biotechs Stocks to Watch: Vertex (NASDAQ:VRTX) and Ariad (NASDAQ:ARIA)
January 24, 2012, Market Playground
Brian Druker wins prestigious Japan Prize
January 24, 2012, Portland Business Journal
Rowley to receive Japan Prize for her role in the development of targeted cancer therapy
January 24, 2012, EurekAlert
Velcade-Belinostat Combination May Be Active In Myelodysplastic Syndromes (ASH 2011)
January 24, 2012,The MDS Beacon
Novartis receives CHMP backing for Glivec label update
January 24, 2012, Zenopa
Chemo Cocktail Produces Better Results
January 24, 2012, DailyRx
Therapy Dose Management During Clinical Development of Oncology Products
January 24, 2012, Drug Discovery & Development
Marathon Against CML Still Not Won
January 24, 2012, DailyRx
Oracle Unveils Oracle® Health Sciences Omics Data Bank as Part of Oracle Health Sciences Translational Research
Center“With the rapidly dropping cost of whole genome sequencing, the challenge for personalized medicine is moving from generation of the data to analysis,” said Dr. Brian Druker
January 23, 2012, Oracle
EMA adopts positive opinion to update Novartis Glivec label to include 3- year treatment for GIST patients after surgery
January 23, 2012, Pharmabiz.com
‘The C-word’ doesn’t slow this family
January 22, 2012, Lake City Reporter.com
Analysis of outcomes in adolescents and young adults with CMLtreated with upfront tyrosine kinase inhibitortherapy
January 22, 2012, Heamatologica
Clinical cardiac safety profile of nilotinib.
January 22, 2012, PubLMed
NCMLS Remembers legendary Etta James
January 21, 2012, NCMLS
Support a Family'- Boyd Dunleavey Leukemia Awareness Day VIDEO
January 21, 2012, CMLeukemia.com
January 31, 2012, MarketWatch
2 Potentially Solid Transdermal Drug Biotechs With Catalysts For 2012
January 31, 2012,Seeking Alpha
Bonney Lake to Host Relay for Life, Mayor Neil Johnson Selected as Guest Speaker
January 30, 2012, Bonney Lake-Sumner Patch
Tasigna Recommended as Second-line CML Therapy - Tasigna receives final recommendation from NICE
January 30, 2012, DailyRx
FDA accepts NDA for Pfizer CML drug
January 30, 2012, Pharmaceutical Business Review
Candid Cancer segment - what to know about getting a second opinion. VIDEO
January 29, 2012, A wider world
Area medical centers provide improvements to cancer treatments
January 28, 2012, greenbaypressgazette.com
CML Update at ASH 2011 - Interview with Elias Jabbour, M.D. VIDEO
January 27, 2012, OncUViewTV
FDA accepts Pfizer leukemia treatment for review
January 27, 2012, CBS Money Watch
Earnings Preview: Pfizer to report on 4th quarter
January 27, 2012, CBS Money Watch
Relentless for a Cure
January 26, 2012, Leukemia & Lymphoma Society
True Chronic Myeloid Leukemia Specific Antigen Vaccines
January 26, 2012, Johnny Silva Cancer Research
Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ CML
January 26, 2012, Pfizer
For CML, Nilotinib Superior to Imatinib at 24 Months
January 26, 2012, Clinical Oncology
Bristol-Myers Misses Analyst Estimates as Costs Increase to Gain New Drugs
January 26, 2012, Bloomberg
BB Biotech closes 2011 with a positive performance and confirms upward trend
January 26 ,2012, Reuters
Understanding Molecular Response with Respect to Cure VIDEO
January 25, 2012, Patient Power
Bill introduced to allow cancer patients access to easier, more affordable chemo
January 25, 2012, WGMD.com
Novartis Drugs Backed by CHMP
January 25 ,2012, Zacks.com
Kareem Abdul-Jabbar – In His Own Words
January 25, 2012, Coping with cancer
Leukemia Drug and Magnet Material Net Japan Prizes
January 25, 2012, Science Insider
HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells
January 24, 2012, Journal Blood
Biotechs Stocks to Watch: Vertex (NASDAQ:VRTX) and Ariad (NASDAQ:ARIA)
January 24, 2012, Market Playground
Brian Druker wins prestigious Japan Prize
January 24, 2012, Portland Business Journal
Rowley to receive Japan Prize for her role in the development of targeted cancer therapy
January 24, 2012, EurekAlert
Velcade-Belinostat Combination May Be Active In Myelodysplastic Syndromes (ASH 2011)
January 24, 2012,The MDS Beacon
Novartis receives CHMP backing for Glivec label update
January 24, 2012, Zenopa
Chemo Cocktail Produces Better Results
January 24, 2012, DailyRx
Therapy Dose Management During Clinical Development of Oncology Products
January 24, 2012, Drug Discovery & Development
Marathon Against CML Still Not Won
January 24, 2012, DailyRx
Oracle Unveils Oracle® Health Sciences Omics Data Bank as Part of Oracle Health Sciences Translational Research
Center“With the rapidly dropping cost of whole genome sequencing, the challenge for personalized medicine is moving from generation of the data to analysis,” said Dr. Brian Druker
January 23, 2012, Oracle
EMA adopts positive opinion to update Novartis Glivec label to include 3- year treatment for GIST patients after surgery
January 23, 2012, Pharmabiz.com
‘The C-word’ doesn’t slow this family
January 22, 2012, Lake City Reporter.com
Analysis of outcomes in adolescents and young adults with CMLtreated with upfront tyrosine kinase inhibitortherapy
January 22, 2012, Heamatologica
Clinical cardiac safety profile of nilotinib.
January 22, 2012, PubLMed
NCMLS Remembers legendary Etta James
January 21, 2012, NCMLS
Support a Family'- Boyd Dunleavey Leukemia Awareness Day VIDEO
January 21, 2012, CMLeukemia.com
December 31, 2011, Tampa Bay Online
Bloomington boy starts 2012 by realizing dream
December 31, 2011, Victoria advocate.com
Early Treatment for CML: A Closer Watch and Newer Options for Better Long-Term Results VIDEO
December 29, 2011, Patient Power
For Phoenix woman, every day a blessing after cancer VIDEO
December 28, 2011, azcentral.com
With India in global network, stem cell transplant to get easier
December 26, 2011, MD India
Fish oil may help cure leukemia
December 22, 2011MedivalXpress
Powered Device Hailed as Advance for Bone Marrow Biopsy
December 22, 2011, Medscape News Today
Promising treatments for blood cancers presented by JTCancerCenter researchers at ASH meeting
December 22, 2011, EurekAlert
Many cancer cases, now manageable, although roadblocks remain
December 22, 2011, USA TODAY Your life
Ariad Pharmaceuticals Still Might Have Upside
December 19, 2011, Journal Blood
The Apothecary Shops Incorporates Innovative Technology Into Patient Medication Reminders
December 19, 2011, PRNewswire
5 Winners Of American Society Of Hematology 2011
December 19, 2011, Seeking Alpha
YM's Positive Results Have Incyte Investors Worried
December 15, 2011, Seeking Alpha
FDA approves update for Tasigna label
December 15, 2011, Modern Medicine
ENEST: Patients with Ph+CML exhibited deeper responses to nilotinib than imatinib mesylate
December 15, 2011, HemoncToday
Study: Two Sisters Suffer From Lymphoma
December 15, 2011, Heal Blog (blog)
ARIAD Secures Much-Needed Capital for Trials, Commercialization, and Growth (ARIA)
December 15, 2011, WallST
CML updatde from 2011 ASH annual meeting
December 14, 2011, Biotech Strategy Blog
Nilotinib shows promise as first-line therapy in CML
December 14, 2011, HemoncToday
Threshold Pharmaceuticals Announces Promising Phase 1 Clinical Trial Results in Patients With Advanced Leukemias
December 14, 2011, MarketWatch
Food Dude: The Sweete Bye and Bye
December 14, 2011, NewOK.com
Brian Druker: My Vision for CML and the Road to a Cure VIDEO
December 13, 2011, Patient Power
More news for ASH meeting
December 13, 2011, The Pharma Letter
Bio-Path Holdings' Initial Phase I Data in Leukemia Clinical Trial Demonstrates That Its Neutral Lipid Delivery Technology Antisense Drug BP-100-1.01 (Liposomal Grb-2) is Well Tolerated with Activity Seen at Low Starting Dose
December 13, 2011, BusinessWire
BELA Trial: Bosutinib May Be Superior to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
December 10, 2011, The Post and Courier
New method to destroy chronic myeloid leukemia cells discovered
December 10, 2011, Health Jockey
The Path of Science and Hope: Ph+ CML VIDEO
December 9, 2011, Novartis
Thorburn: Like home runs, singles can lead to wins against cancer mortality
December 9, 2011, Colorado Cancer blog
Scientists discover how to beat resistance to standard leukaemia drug
December 9, 2011, MedicalXPress
Scientists discover how to beat resistance to standard leukaemia drug
December 8, 2011, Cancer Research UK
Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Efficacy Data Against Lymphoid Cancers at the 53rd Annual Meeting of the American Society of Hematology (ASH)
December 8, 2011, MarketWatch
NICE backs two Novartis CML drugs; BMS denied
December 7, 2011, PMLive
ASH Calls on Congress to Take Action to Prevent Drug Shortages
December 6, 2011, The American Society of Hematology
ARIAD to Present at the Oppenheimer 22nd Annual Healthcare Conference
December 6, 2011, MarketWatch
Nice has recommended Glivec, Tasigna for the first line treatment of CML
December 6, 2011, The National Institute for Health and Clinical Excellence (NICE)
NICE Backs Novartis' Glivec, Tasigna for CML, Rejects Sprycel
December 6, 2011, NASDAQ
Experts Question Benefits of High-Cost Cancer Care
December 5, 2011, Medscape News
ARIAD Announces Investor Meeting and Webcast at American Society of Hematology Meeting
December 5, 2011, MarketWatch
When "personalized gene-targeted cancer therapy" really means "making it up as you go along"
December 5, 2011, ScienceBlogs
What's Hot at ASH 2011?
December 2, 2011, Medscape Today
Novartis highlights advances for patients with breast cancer and hematological diseases with over 160 SABCS and ASH abstracts
December 2, 2011, Reuters
Patients suffering from blood cancer: Khyber Pakhtunkhwa government launches Rs 7.2 billion free treatment project
December 2, 2011, Business Recorder
2011 ASH Annual Meeting to Highlight Latest Hematology Research, Clinical Care Breakthroughs
December 1, 2011, American Society of Hematology
2011 ASH Annual Meeting to Highlight Latest Hematology Research, Clinical Care Breakthroughs
December 1, 2011, Sacramento Bee
Which is better for Chronic Myeloid Leukemia?
December 1, 2011, DailyRx
2011 ASH Annual Meeting to Highlight Latest Hematology Research, Clinical Care Breakthroughs
December 1, 2011, PRNewswire
National experts from the John Theurer Cancer Center will present 31 studies at the 2011 ASH Meeting
December 1, 2011, Physorg.com
New Method That Reveals Complete Set of Aberrant Signaling Pathways That Give Rise to Cancers
December 1, 2011, HealthNewsDigest.com
OTCtipReporter.com: OncoVista Innovative Therapies, Inc. (OTCBB: OVIT), Amwest Imaging Incorporated (OTCBB: AMWI), Umami Sustainable Seafood Inc. (OTCBB: UMAM): Sign up for our FREE Stock Picks Today!
November 30, 2011, TechZone360
Menthol Cigarettes Not Less Harmful, say Experts
November 28, 2011, DailyRX
OncoVista Innovative Therapies Engages Oncology Therapeutic Development to Initiate a Phase Ib Study of Cordycepin in Patients With Refractory TdT Positive Leukemia
November 28, 2011,MarketWatch
ARIAD to Present at the 2011 Deutsche Bank BioFEST
November 28, 2011, MarketWatch
New CML Health Education Center on Patient Power
November 26, 2011, TheEveningSun
Expanding Chronic Myeloid Leukemia Treatment Options
November 26, 2011, dailyRX
Schusterman Caps Israel-to-Tulsa Oil Career With KKR Sale
November 25,2011, Bloomberg Businessweek
Wakeboarder battles Leukemia, but she 'lives strong' VIDEO
November 24, 2011, My Fox Orlando
A giving sacrifice - Her five year old son was diagnosed with CML just under two years ago
November 22, 2011, DailyRX
BIG Girls Care this Holiday Season
November 21, 2011, Trib Local BurrRidge/Willowbrook
Medical Resources: Understanding Leukemia
November 21, 2011, Boston.com
MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
November 19, 2011, Central Wisconsin hub
The Importance of Drugs From the Sea
November 17, 2011, Business Wire
Finding Emotional Support for Long-term Illness
November 16, 2011, OncologyNurseAdvisor
Coaches for Cancer Tournament
November 16, 2011, abc4.com
How cancer has made me feel like the luckiest person around
November 15, 2011, Parenting Post
Donating marrow through the Be The Match Registry could save a life
November 15, 2011, Courier-Herald
Bobcats help lift leukemia-stricken fan
November 15, 2011, Bozeman Daily Chronicle
Laboratory honors NBA icon, researchers
November 15, 2011, Newsday
Signs, Symptoms and Definition of Leukemia
November 15, 2011, EmpowHer
Franchisee Battles New Storm against Pizza Hut
Laura Boyd’s skate expectations
January 21, 2012, The Scottish Sun
Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa.
January 20, 2012, International Journal of Hematology
CHMP recommends EU approval to update Novartis drug Glivec(R) label to include three year treatment for GIST patients after surgery
January 20, 2012, Reuters
Cancer classic personal for NB's Kevin Bianco
January 19, 2012, NorthJersey.com
Analyst sees Ariad primed for acquisition
January 19, 2012, MassHighTech
Research and Markets: Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, H2, 2011
January 19, 2011, Business Wire
Analyst: Red-hot Ariad is a possible acquisition target
January 19, 2012, Business journal
Alisa Peinhardt, an experienced oncology nurse, now serves as the Director of Patient Care Services for the National CML Society VIDEO
January 18, 2012, Patient Power
A CML Patient Advocate's Perspective on ASH 2011 VIDEO
January 18, 2012, Patient Power
Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+chronic myeloid leukemia progenitors preserving normal stem cells
January 18, 2012, Journal Blood
Abdul-Jabbar named State Department cultural ambassador
January 18, 2012, USA Today
Wollondilly urged to enter World's Greatest Shave
January 17, 2012, Macarthur chronicle
Discount wins final NICE OK for Tasigna
January 17, 2012, Pharma Times
Working toward a cure: Penn State duo developing fish oil-based leukemia treatment
January 16, 2012, Centredaily.com
Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives
January 15, 2012, PubLMed
Cancer treatment: Are Personalized Molecular Profiles in Our Future?
January 13, 2012, PBS Newshour
Continuing Good News for Chronic Myeloid Leukemia Patients
January 13, 2012, Cancer Network
Did You Buy These Stocks?
January 13, 2012, Nasdaq
CORRECT: NICE Backs Novartis's Tasigna For CML, Rejects BMS's Sprycel
January 13, 2012, the Wall Street Journal
Mixed NICE recommendations for CML and diabetes drugs
January 13, 2012, The Pharma Letter
Concert to benefit high school student
January 13, 2012, wausaudailyherald.com
No longer a bitter pill to swallow (chidren)
January 13, 2012, dailyRx
Cancer drugs should be treated equally
January 12, 2012, The Columbus Dispatch
More Than a Decade of CML Experience at OHSU Knight Cancer Institute VIDEO
January 12, 2012, Patient Power
Kedem Pharmaceuticals Initiates Development of Sublingual Anti-Cancer Drug, Gleevec
January 12, 2012, The Sacremento Bee
Living With Chronic Myelogenous Leukemia - Side Effects and Symptom Management VIDEO
January 11, 2012, Patient Power
Ariad: This Bio-Pharma May Deliver Big Returns
January 11, 2012, Seeking Alpha
Kayla Nation: Young Mother with CML Perseveres VIDEO
January 9, 2012, Patient Power
Trivia night to benefit Ronnie Buckwalter
January 9, 2012, AledoTimesRecord.com
Condolences to the family of Zavie Miller
January 9, 2012, CML World
Sharing News
January 9, 2012, Work in progress
AccuGenomics to Attend OneMedForum with Standardized Gene Expression Tests for Leukemia and Lung Cancer
January 7, 2012, SFGate
Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience
January 6, 2012, Journal Blood
Korean Pharmaceutical Company Develops New Leukemia Treatment
January 6, 2012, Arirang
AccuGenomics to Attend OneMedForum with Standardized Gene Expression Tests for Leukemia and Lung Cancer
January 6, 2012, PRNewswire
S. Korea approves Asia's first anti-leukemia drug
January 5, 2012, OANA News
KP treats local and Afghan leukemia patients free
January 4, 2012, Central Asia Online
AccuGenomics Seeks to Standardize Gene Expression Tests for Early Leukemia, Lung Cancer Detection
January 4, 2012, OneMedPlace
Brian Druker: Compassionate Care and Personalized Medicine VIDEO
January 3, 2012, Patient Power
TrovaGene, Inc. Obtains Exclusive License to Novel Mutations Associated with Prognosis and Chemotherapy Response in Leukemia
January 3, 2012, PRNewswire
Afghans’ free treatment: Health dept fears audit objections
January 2, 2012, Dawncom
November 10, 2011, The Post Chronicle
CML Patients May Need Fewer Bone Marrow Biopsies in the Future VIDEO
November 10, 2011, Patient Power
Tamera Simonson: 19-year CML Survivor VIDEO
November 10, 2011, Patient Power
New Evidence for Taking Medication at the Right Dose VIDEO
November 10, 2011, Patient Power
National Caregiver Month recognizes and supports those helping care for loved ones
November 8, 2011,PRNewswire
CytRx Reports Third Quarter 2011 Financial Results – (Bafetinib, CML)
November 8, 2011, MarketWatch
Mini-Transplants - Age no longer barrier to stem cell transplants for older patients
November 7, 2011, Seattle Cancer Care Alliance
Ariad Pharma: Early Efficacy, Safety of Leukemia Drug 'Striking'
November 6, 2011, Livingston Daily
Changing lives one run at a time
November 6, 2011, Florida Today
Good adherence to imatinib therapy among patients with chronic myeloid leukemia-a single-center observational study.
November 3, 2011, CancerCancel
Dr. Ruben Mesa Joins 23andMe's Myeloproliferative Neoplasms Initiative as Scientific Advisor
August 23, 2011, Borehamwood & Elstree Times
ENESTnd: Nilotinib superior to imatinib for response, disease-specific death in chronic-phase CML at 2 years
August 23, 2011, Hemonc today
Pfizer Announces European Medicines Agency Acceptance of Regulatory Submissions For Two Investigational Cancer Therapies
August 23, 2011, Vadvert.co.uk
CytRx President and CEO Steven Kriegsman and CMO Dr. Daniel Levitt Discuss Company Advantages and Oncology Clinical Pipeline Attributes in OncLive Interview
August 22, 2011, Market Watch
Nilotinib Still Trumps Imatinib in Chronic CML
August 20, 2011,Medpage Today
20-Year Leukemia Survivor to Wed; Bay Area Woman Gives Back to Others Facing Similar Plight
August 19, 2011,Rafu.com
New discount persuades NICE to back Novartis' Tasigna
August 18, 2011,InPharm
Leukaemia patients given hope by NHS drugs watchdog
August 18, 2011, The Telegraph
European Watchdog OKs Pfizer Drugs
August 18, 2011, Zacks
Expert Insights: CML Updates From Summer 2011
August 17, 2011, Medscape education
Bio-Path Holdings Reports Second Quarter 2011 Financial Results
August 15, 2011, Business Wire
Cepheid Launches New Test
August 15, 2011, Daily Markets
Bonney Lake Mayor Steps Away from Civic Duties to Undergo Cancer Treatment
August 15, 2011,BonneyLake-SumnerPatch
Free medication for Blood Cancer at SCB
August 14, 2011, IBNLive
First Cohort Successfully Completed in Bio-Path Holdings' Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2 in Leukemia
August 11, 2011, The Wall Street Journal
China Medical receives SFDA approval for 2 diagnostic tests
August 11, 2011, Proactiveinvestors
'Serial killer' cells eradicate leukemia tumours
August 10, 2011, CTV.ca
New leukemia treatment exceeds 'wildest expectations'
August 10, 2011, MSNBC.com
Cepheid Announces Release of Updated Xpert BCR-ABL Monitor Test
August 9, 2011, The Sacremento Bee
Bcr-abl signals to desensitize chronic myeloid leukemia cells to interferon alpha via accelerating the degradation of its receptor
August 5, 2011, Journal Blood
Other Diseases, Age, and Disease Status May Predict Outcome In MDS Patients Undergoing Reduced-Intensity Transplantation
August 5, 2011, The MDS Beacon
Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia
August 3, 2011, Cold Spring Harbor Laboratory
How Do Tumors Grow?
August 2, 2011, Scientific American
Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line
August 2, 2011, 7th Space
ARIAD shares rise on EU review of potential cancer drug
August 1, 2011, Boston Business Journal
CML Patients May Need Fewer Bone Marrow Biopsies in the Future VIDEO
November 10, 2011, Patient Power
Tamera Simonson: 19-year CML Survivor VIDEO
November 10, 2011, Patient Power
New Evidence for Taking Medication at the Right Dose VIDEO
November 10, 2011, Patient Power
National Caregiver Month recognizes and supports those helping care for loved ones
November 8, 2011,PRNewswire
CytRx Reports Third Quarter 2011 Financial Results – (Bafetinib, CML)
November 8, 2011, MarketWatch
Mini-Transplants - Age no longer barrier to stem cell transplants for older patients
November 7, 2011, Seattle Cancer Care Alliance
Ariad Pharma: Early Efficacy, Safety of Leukemia Drug 'Striking'
November 6, 2011, Livingston Daily
Changing lives one run at a time
November 6, 2011, Florida Today
Good adherence to imatinib therapy among patients with chronic myeloid leukemia-a single-center observational study.
November 3, 2011, CancerCancel
Dr. Ruben Mesa Joins 23andMe's Myeloproliferative Neoplasms Initiative as Scientific Advisor
August 23, 2011, Borehamwood & Elstree Times
ENESTnd: Nilotinib superior to imatinib for response, disease-specific death in chronic-phase CML at 2 years
August 23, 2011, Hemonc today
Pfizer Announces European Medicines Agency Acceptance of Regulatory Submissions For Two Investigational Cancer Therapies
August 23, 2011, Vadvert.co.uk
CytRx President and CEO Steven Kriegsman and CMO Dr. Daniel Levitt Discuss Company Advantages and Oncology Clinical Pipeline Attributes in OncLive Interview
August 22, 2011, Market Watch
Nilotinib Still Trumps Imatinib in Chronic CML
August 20, 2011,Medpage Today
20-Year Leukemia Survivor to Wed; Bay Area Woman Gives Back to Others Facing Similar Plight
August 19, 2011,Rafu.com
New discount persuades NICE to back Novartis' Tasigna
August 18, 2011,InPharm
Leukaemia patients given hope by NHS drugs watchdog
August 18, 2011, The Telegraph
European Watchdog OKs Pfizer Drugs
August 18, 2011, Zacks
Expert Insights: CML Updates From Summer 2011
August 17, 2011, Medscape education
Bio-Path Holdings Reports Second Quarter 2011 Financial Results
August 15, 2011, Business Wire
Cepheid Launches New Test
August 15, 2011, Daily Markets
Bonney Lake Mayor Steps Away from Civic Duties to Undergo Cancer Treatment
August 15, 2011,BonneyLake-SumnerPatch
Free medication for Blood Cancer at SCB
August 14, 2011, IBNLive
First Cohort Successfully Completed in Bio-Path Holdings' Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2 in Leukemia
August 11, 2011, The Wall Street Journal
China Medical receives SFDA approval for 2 diagnostic tests
August 11, 2011, Proactiveinvestors
'Serial killer' cells eradicate leukemia tumours
August 10, 2011, CTV.ca
New leukemia treatment exceeds 'wildest expectations'
August 10, 2011, MSNBC.com
Cepheid Announces Release of Updated Xpert BCR-ABL Monitor Test
August 9, 2011, The Sacremento Bee
Bcr-abl signals to desensitize chronic myeloid leukemia cells to interferon alpha via accelerating the degradation of its receptor
August 5, 2011, Journal Blood
Other Diseases, Age, and Disease Status May Predict Outcome In MDS Patients Undergoing Reduced-Intensity Transplantation
August 5, 2011, The MDS Beacon
Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia
August 3, 2011, Cold Spring Harbor Laboratory
How Do Tumors Grow?
August 2, 2011, Scientific American
Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line
August 2, 2011, 7th Space
ARIAD shares rise on EU review of potential cancer drug
August 1, 2011, Boston Business Journal
Funding veterinary medicine advances cancer treatments of human patients
July 29, 2011, OpenPR
NanoString Offers New Tool for Analyzing 25 Leukemia Fusion Genes in a Single Reaction
July 28, 2011, BusinessWire
Cancer can't hold back Minnesota wakeboarder VIDEO
July 27, 2011, Startribune.com
Scientists Integrate Single-Cell Processing and RT-qPCR for Parallel Analysis of Hundreds of Cells
July 27, 2011, GEN
NSAIDs associated with reduced risk for myeloid leukemias in adult women
July 26, 2011,Hemonctoday
Obesity and the risk of chronic myelogenous leukemia: is this another example of the neoplastic effects of increased body fat?
July 22, 2011, Leukemia
Canadians newly diagnosed with chronic myeloid leukemia now have new treatment option
July 22, 2011, CNW
A report from the front line of cancer treatment
July 20. 2011, io9.com
Sunesis Announces Publication of Phase 1b Data of Vosaroxin in Relapsed or Refractory Acute Leukemia
July 20, 2011, MarketWatch.com
Is your car killing you with benzene?
July 19, 2011, American Cancer Society
John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting
July 18, 2011, Physorg.com
Optimizing the Selection of Kinase Inhibitors for Chronic Myeloid Leukemia Patients
July 15, 2011, Medscape News
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population
July 12, 2011, Journal Blood
The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors.
July 11, 2011, PublMed
Biomarker Predicts Worse Outcome in Chronic Myeloid Leukemia
July 11, 2011, The Oncology Report
Association of community cancer centers’ education project reveals most effective practices for treating CML patients in the community setting
July 11, 2011, Media Newswire
Patients Abandon Oral Chemotherapies Due to High Copays
July 2011, ClinicalOncology
One of the ‘’Easy Cancers’’
July 9, 2011, dailyRX
Man Claims Sunscreen Gave Him Leukemia
July 8, 2011, Courthouse News Service
Marker Found that Enables Segregation of True Human Hematopoietic Stem Cells from Multipotent Progenitors
July 8, 2011, GEN News
Found: the mother of all blood cells
July 7, 2011,NewScientist
The American Society of Hematology Honors Janet Rowley, MD, and Brian Druker, MD, with Ernest Beutler Lecture and Prize
July 7, 2011, Hematology.org
Worcestershire campaign to keep NHS leukaemia drug
July 5, 2011, News Hereford & Worcester
Transforming a diagnosis into inspiration
July 1, 2011, Las Vegas Review-Journal
Coventry Resident Attempts 100-Plus Mile Swim for Charity
July 1, 2001,CoventryPatch
July 29, 2011, OpenPR
NanoString Offers New Tool for Analyzing 25 Leukemia Fusion Genes in a Single Reaction
July 28, 2011, BusinessWire
Cancer can't hold back Minnesota wakeboarder VIDEO
July 27, 2011, Startribune.com
Scientists Integrate Single-Cell Processing and RT-qPCR for Parallel Analysis of Hundreds of Cells
July 27, 2011, GEN
NSAIDs associated with reduced risk for myeloid leukemias in adult women
July 26, 2011,Hemonctoday
Obesity and the risk of chronic myelogenous leukemia: is this another example of the neoplastic effects of increased body fat?
July 22, 2011, Leukemia
Canadians newly diagnosed with chronic myeloid leukemia now have new treatment option
July 22, 2011, CNW
A report from the front line of cancer treatment
July 20. 2011, io9.com
Sunesis Announces Publication of Phase 1b Data of Vosaroxin in Relapsed or Refractory Acute Leukemia
July 20, 2011, MarketWatch.com
Is your car killing you with benzene?
July 19, 2011, American Cancer Society
John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting
July 18, 2011, Physorg.com
Optimizing the Selection of Kinase Inhibitors for Chronic Myeloid Leukemia Patients
July 15, 2011, Medscape News
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population
July 12, 2011, Journal Blood
The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors.
July 11, 2011, PublMed
Biomarker Predicts Worse Outcome in Chronic Myeloid Leukemia
July 11, 2011, The Oncology Report
Association of community cancer centers’ education project reveals most effective practices for treating CML patients in the community setting
July 11, 2011, Media Newswire
Patients Abandon Oral Chemotherapies Due to High Copays
July 2011, ClinicalOncology
One of the ‘’Easy Cancers’’
July 9, 2011, dailyRX
Man Claims Sunscreen Gave Him Leukemia
July 8, 2011, Courthouse News Service
Marker Found that Enables Segregation of True Human Hematopoietic Stem Cells from Multipotent Progenitors
July 8, 2011, GEN News
Found: the mother of all blood cells
July 7, 2011,NewScientist
The American Society of Hematology Honors Janet Rowley, MD, and Brian Druker, MD, with Ernest Beutler Lecture and Prize
July 7, 2011, Hematology.org
Worcestershire campaign to keep NHS leukaemia drug
July 5, 2011, News Hereford & Worcester
Transforming a diagnosis into inspiration
July 1, 2011, Las Vegas Review-Journal
Coventry Resident Attempts 100-Plus Mile Swim for Charity
July 1, 2001,CoventryPatch
Too much of a good thing, not so good
October 21, 2011, bclocalnews.com
Myelodysplasia gene mutation can aid diagnosis
October 21, 2011, OncologyNurseAdvisor
Leukemia still a threat despite years of treatment? Blame stem cells
October 20, 2011, City of Hope
Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies
October 20, 2011, Journal Blood
Changes in the dynamics of the excess mortality rate in chronic phase-chronic myeloid leukemia over 1990-2007: a population study
October 20, 2011, Journal Blood
New Smyrna man needs match for bone marrow transplant
October 20, 2011, The Daytona Beach New- Journal
Benzene Wrongful Death Lawsuit Results in $7.5M Verdict
October 18, 2011, AboutLawsuits.com
New cancer meds caught in insurance squeeze
October 14, 2011, MiamiHerald.com
Leukemia patient turns to social media to save his own life
October 13, 2011, The Takeaway
Imatinib is receptive to a collaboration
October 13, 2011, Journal Blood
Finding clues in our blood
October 12, 2011, northshoreoflongisland.com
ARIAD to Present at the 18th Annual Newsmakers in the Biotech Industry Conference
October 12, 2011, Business Wire
CML-Expert Information About Diagnosis and Treatment - A Live Telephone/Web Education Program Offering Live Spanish Interpretation Featuring International CML Expert Michael J. Mauro, MD
October 11, 2011, MarketWatch
FDA: Increased PAH Risk Seen With Dasatinib
October 11, 2011, Internal Medicine News Digital Network
Steve Jobs' Death Spotlights Hard-to-Detect Cancers
October 6, 2011, Fox News
Keeping his faith: Fundraiser benefits area musician battling cancer
October 4, 2011, The Advertiser.com
CytRx's ENABLE Phase 2 Trial Results with Bafetinib in Relapsed B-Cell Chronic Lymphocytic Leukemia to be Presented at the Prestigious 53rd Annual ASH Meeting
October 4, 2001, MarketWatch
Initial Data from Bio-Path Holdings' Phase I Clinical Trial Accepted for Presentation at American Society of Hematology Annual Meeting
October 4, 2011, MarketWatch
Navigating the Net Wisely in a Health Crisis
October 3, 2011, New York Times
Leukemia stem cells are a lingering threat despite many years of treatment
October 3, 2011, City of Hope
CV drug shows promise as a leukemia treatment
October 3, 2011, OncologyNurseAdvisor
Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice
October 2, 2004, Journal Blood
October 21, 2011, bclocalnews.com
Myelodysplasia gene mutation can aid diagnosis
October 21, 2011, OncologyNurseAdvisor
Leukemia still a threat despite years of treatment? Blame stem cells
October 20, 2011, City of Hope
Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies
October 20, 2011, Journal Blood
Changes in the dynamics of the excess mortality rate in chronic phase-chronic myeloid leukemia over 1990-2007: a population study
October 20, 2011, Journal Blood
New Smyrna man needs match for bone marrow transplant
October 20, 2011, The Daytona Beach New- Journal
Benzene Wrongful Death Lawsuit Results in $7.5M Verdict
October 18, 2011, AboutLawsuits.com
New cancer meds caught in insurance squeeze
October 14, 2011, MiamiHerald.com
Leukemia patient turns to social media to save his own life
October 13, 2011, The Takeaway
Imatinib is receptive to a collaboration
October 13, 2011, Journal Blood
Finding clues in our blood
October 12, 2011, northshoreoflongisland.com
ARIAD to Present at the 18th Annual Newsmakers in the Biotech Industry Conference
October 12, 2011, Business Wire
CML-Expert Information About Diagnosis and Treatment - A Live Telephone/Web Education Program Offering Live Spanish Interpretation Featuring International CML Expert Michael J. Mauro, MD
October 11, 2011, MarketWatch
FDA: Increased PAH Risk Seen With Dasatinib
October 11, 2011, Internal Medicine News Digital Network
Steve Jobs' Death Spotlights Hard-to-Detect Cancers
October 6, 2011, Fox News
Keeping his faith: Fundraiser benefits area musician battling cancer
October 4, 2011, The Advertiser.com
CytRx's ENABLE Phase 2 Trial Results with Bafetinib in Relapsed B-Cell Chronic Lymphocytic Leukemia to be Presented at the Prestigious 53rd Annual ASH Meeting
October 4, 2001, MarketWatch
Initial Data from Bio-Path Holdings' Phase I Clinical Trial Accepted for Presentation at American Society of Hematology Annual Meeting
October 4, 2011, MarketWatch
Navigating the Net Wisely in a Health Crisis
October 3, 2011, New York Times
Leukemia stem cells are a lingering threat despite many years of treatment
October 3, 2011, City of Hope
CV drug shows promise as a leukemia treatment
October 3, 2011, OncologyNurseAdvisor
Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice
October 2, 2004, Journal Blood
Will every patient be an "N-of-1" when it comes to cancer?
September 30, 2011, Medpage Today
Andrew Matheson, The Point After: Watsonville's comeback kid living life on the field while battling leukemia
September 30, 2011, Santa Cruz Sentinel
Research and Markets: Global Chronic Myeloid Leukemia Drug Pipeline Capsule - 2011
September 28, 2011, Bradenton.com
Benzene Leukemia Lawsuit Filed by Man Who Grew Up Near Oil Refinery
September 27, 2011, aboutlawsuits.com
Data from Evaluation of Signature(R) LTx Leukemia Test to Be Presented at Upcoming Planet XMAP
September 27, 2011, Marketwatch
Vaccine researchers find a possible new approach to overcoming leukemia
September 26, 2011, City of Hope
ARIAD continues to achieve endpoints in ponatinib follow-up
September 26, 2011, Proactive Investors
The National CML Society and NBA's all-time leading scorer team up against leukemia, one anniversary at a time
September 24, 2011, Las Vegas Review-Journal
Reflections on Advocacy: Making Our Voices Heard - NCMLS on Capitol Hill 9/20/11
September 23, 2011, The National CML Society
How International CML Day in India was celebrated
September 23, 2011, The Max Foundation
Studying blood cancers has helped unlock mysteries of disease, paved the way to better treatments
September 23, 2011, AnnArbor.com
CML Awareness Day and Joy Smith, MP
September 23, 2011, Digital Journal
CML - Pathways to Discovery - Dr. Janet D. Rowley VIDEO
September 22, 2011, NationalCMLSociety
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
September 22, 2011, Blood Journal
The CML Society Marks CML Awareness Day with Stepping Stone Ceremonies
September 22, 2011, Digital Journal
Annual Nobel Predictions Announced, but Forecasting Prizes Remains a Tricky Business
September 21, 2011, Scientific American
Spooky theory, leukemia drugs top Nobel tips: Thomson Reuters
September 21, 2011, Reuters
How Thai doctors are having success treating a common form of leukaemia
September 20, 2011, Bangkok Post
International CML Day – Health Corner
September 20,2011, ExpressIndia
Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment.
September 19, 2011, Journal Blood
Pat Shares Her Health Story And Her Life As A Two Time Cancer Survivor VIDEO
September 15, 2011, EmpowHER
Convocation keynote: Keep the excitement of research and patient care alive
September 15, 2011, University of Massachusetts Medical School
Making the Miraculous Happen
September 15, 2011, Sherdog
Brazilian Hair Treatment Comes Under F.D.A. Fire
September 14, 2011, New York Times
Abandoned premature baby now Iraqi vet who lost both legs, cancer survivor searches for real parents
September 13, 2011, Daily News
An Immune System Trained to Kill Cancer
September 13, 2011, The New York Times
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
September 12, 2011, The Journal of experimaqntal medicine
Cardiovascular drug may offer new treatment for some difficult types of leukemia
September 12, 2011, EurekAlert
Nilotinib vs. Imatinib: Development of BCR-ABL Mutations
September 2011’, Volume 06:09, Clinical Oncology
Novartis Must Not Win This Case
September 10, 2011, News Click
NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR–ABL-positive mice
Septembre 9, 2011, Leukemia
India’s drug ‘lifeline’ under threat
September 8, 2011, New Internationalist
Acute leukemia gene seemingly unfolded
September 8, 2011, HealthJockey.com
Nilotinib trumps imatinib in leukemia study
September 7, 2011, OncologyNurseAdvisor
Glivec case transferred to new apex court Bench
September 6, 2011, Business Line
Leukemia Predisposition Gene Discovered
September 5, 2011, Medical News Today
Cancer survivor fights disease through advocacy work
September 2, 2011, Coastweek.com
Modified Citrus Pectin Packs Powerful Immune Punch
September 1, 2011, The Wall Street Journal
Ottawa issues warning about leukemia drug
September 1, 2011, The Chronicle Herald
September 30, 2011, Medpage Today
Andrew Matheson, The Point After: Watsonville's comeback kid living life on the field while battling leukemia
September 30, 2011, Santa Cruz Sentinel
Research and Markets: Global Chronic Myeloid Leukemia Drug Pipeline Capsule - 2011
September 28, 2011, Bradenton.com
Benzene Leukemia Lawsuit Filed by Man Who Grew Up Near Oil Refinery
September 27, 2011, aboutlawsuits.com
Data from Evaluation of Signature(R) LTx Leukemia Test to Be Presented at Upcoming Planet XMAP
September 27, 2011, Marketwatch
Vaccine researchers find a possible new approach to overcoming leukemia
September 26, 2011, City of Hope
ARIAD continues to achieve endpoints in ponatinib follow-up
September 26, 2011, Proactive Investors
The National CML Society and NBA's all-time leading scorer team up against leukemia, one anniversary at a time
September 24, 2011, Las Vegas Review-Journal
Reflections on Advocacy: Making Our Voices Heard - NCMLS on Capitol Hill 9/20/11
September 23, 2011, The National CML Society
How International CML Day in India was celebrated
September 23, 2011, The Max Foundation
Studying blood cancers has helped unlock mysteries of disease, paved the way to better treatments
September 23, 2011, AnnArbor.com
CML Awareness Day and Joy Smith, MP
September 23, 2011, Digital Journal
CML - Pathways to Discovery - Dr. Janet D. Rowley VIDEO
September 22, 2011, NationalCMLSociety
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
September 22, 2011, Blood Journal
The CML Society Marks CML Awareness Day with Stepping Stone Ceremonies
September 22, 2011, Digital Journal
Annual Nobel Predictions Announced, but Forecasting Prizes Remains a Tricky Business
September 21, 2011, Scientific American
Spooky theory, leukemia drugs top Nobel tips: Thomson Reuters
September 21, 2011, Reuters
How Thai doctors are having success treating a common form of leukaemia
September 20, 2011, Bangkok Post
International CML Day – Health Corner
September 20,2011, ExpressIndia
Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment.
September 19, 2011, Journal Blood
Pat Shares Her Health Story And Her Life As A Two Time Cancer Survivor VIDEO
September 15, 2011, EmpowHER
Convocation keynote: Keep the excitement of research and patient care alive
September 15, 2011, University of Massachusetts Medical School
Making the Miraculous Happen
September 15, 2011, Sherdog
Brazilian Hair Treatment Comes Under F.D.A. Fire
September 14, 2011, New York Times
Abandoned premature baby now Iraqi vet who lost both legs, cancer survivor searches for real parents
September 13, 2011, Daily News
An Immune System Trained to Kill Cancer
September 13, 2011, The New York Times
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
September 12, 2011, The Journal of experimaqntal medicine
Cardiovascular drug may offer new treatment for some difficult types of leukemia
September 12, 2011, EurekAlert
Nilotinib vs. Imatinib: Development of BCR-ABL Mutations
September 2011’, Volume 06:09, Clinical Oncology
Novartis Must Not Win This Case
September 10, 2011, News Click
NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR–ABL-positive mice
Septembre 9, 2011, Leukemia
India’s drug ‘lifeline’ under threat
September 8, 2011, New Internationalist
Acute leukemia gene seemingly unfolded
September 8, 2011, HealthJockey.com
Nilotinib trumps imatinib in leukemia study
September 7, 2011, OncologyNurseAdvisor
Glivec case transferred to new apex court Bench
September 6, 2011, Business Line
Leukemia Predisposition Gene Discovered
September 5, 2011, Medical News Today
Cancer survivor fights disease through advocacy work
September 2, 2011, Coastweek.com
Modified Citrus Pectin Packs Powerful Immune Punch
September 1, 2011, The Wall Street Journal
Ottawa issues warning about leukemia drug
September 1, 2011, The Chronicle Herald
Stopping Dasatinib and Nilotinib Explored in Chronic Myeloid Leukemia
June 30, 2011, Oncology Stat
Lincoln Leukaemia patient protests cancer funds withdrawal
June 30, 2011, Lincolnshire
Using the Web to understand your medical condition
June 29, 2011, Komonews.com
Inovio Pharmaceuticals' Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
June 29, 2011, PrNewswire
Tasigna receives Canadian approval
June 27, 2011, CNW
The Latest Weapon Against Cancer: Evolution
June 25, 2011, The Wall Street Journal
A message from a mending heart
June 25, 2011, Dayton Daily News
Bill Would Ensure Patient Access to Oral Chemotherapies
June 23, 2011, wgrz.com
Ph: not bad at all
June 22, 2011, Journal Blood
Evaluation of BCR-ABL monitoring in Chronic Myelogenous Leukemia in clinical practice VIDEO
June 21, 2011, OncUViewTV
Is There a Virus-Versus-Leukemia Effect?
June 21, 2011, CancerNetwork
Health groups want accessible drugs
June 21, 2011, WWLP.com
Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML
June 21, 2011, Journal Blood
Imatinib sensitivity in BCR-ABL1-positive chronic myeloid leukemia cells is regulated by the remaining normal ABL1 allele
June 21, 2011, Cancer Research
Nilotinib Beats Imatinib at 24 Months in Treatment of CML
June 20, 2011, MedscapeToday
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
June 20, 2011, Journal of Clinical Oncology
Cancer survivors beat the odds, graduate high school VIDEO
June 20, 2011, MSNBC.com
Ariad Pharma - Ahead Of PACE
June 17, 2011, RTTNews
Race brings out the best in survivors
June 17, 2011, adn.com
Faster Response Rates in CML with Bosutinib
June 15, 2011, MedscapeToday
The ghost of personalized medicine
June 14, 2011, The Scientist
Towards a more efficient therapy for a specific form of leukemia
June 14, 2011, AlphaGalileo
Webcasts of EHA Education Sessions are well worth watching
June 14, 2011, Biotech Strategy Blog
Treatment of chronic phase (CP) chronic myeloid leukemia (CML) patients who harbour the BCR-ABL T315I mutation with subcutaneous omacetaxine results in improved survival compared to historical data
June 12 2011, EHA 2011
Cessation of dasatinib or nilotinib therapy in chronic- phase chronic myeloid leukaemia patients with sustained complete molecular responses
June 12, 2011, EHA 2011
CML patients treated with TKI’s who obtain major molecular response are highly protected for transformation and this protection seems to be independent of the 18-month cutoff
June 11, 2011, EHA 2011
A molecular criteria have now been defined to guide decisions about if and when to use dasatinib or nilotinib VIDEO
June 11, 2011, ecancecr,tv
1 of the girls
June 9, 2011, dallasvoice.com
Leukaemia patients protest in Manchester at drugs threat
June 9, 2011, BBC - News Manchester
Cancer survivor: Tell people what you're going through
June 9, 2011, Rapid City Journal
Nilotinib Superior to Imatinib, Fewer Mutations in Treatment of CML-CP
June 6, 2011, Monthly Prescribing Reference
Improved survival in chronic myeloid leukemia (CML) since introduction of imatinib therapy: A single-institution experience in 1,570 patients referred within 1 month from diagnosis
June 6, 2011, ASCO 2011
A new symptom measure in chronic myeloid leukemia
June 6, 2011, ASCO 2011
Not his best time, but 'best' race for veteran runner
June 5, 2011, Sign on San Diego
Bosutinib Achieves Faster Response Rates in Newly Diagnosed Chronic Phase CML Patients Than Imatinib
June 3 , 2011, Monthly Prescribing Reference
Dasatinib Shows Superior Efficacy and Acceptable Tolerability, Supporting First-Line Use in Newly Diagnosed CML-CP
June 3 , 2011, Monthly Prescribing Reference
Leukemia drug tied to impaired growth in kids
June 2, 2011, Caring4Cancer
What can nurses do to help cancer survivors?
May 31, 2011, NursingTimes.com
Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis
May 31, 2011, PubLmed
Reframing our thinking about cancer
May 26, 2011, Benefits Canada
Developer of Gleevec sees potential for more cancer drugs, will speak at Moffitt Cancer Center
May 26, 2011, tampabay.com
New Protein Linked to Alzheimer's Disease
May 25, 2011, Science Daily
Understanding Targeted Treatments
May 25, 2011, Cancer.net
Children’s Hospital Los Angeles Team Discovers Key to Fighting Drug-Resistant Leukemia
May 18, 2011, Enhanced Online News
Improved Survival And Treatment For Chronic Blood Disorders
May 18, 2011, Medical News Today
New approach to overcoming TKI resistance
May 18, 2001, ecancermedicalnews
Low incidence rate of opportunistic and viral infections during imatinib
treatment in chronic myeloid leukemia patients in early and late chronic phase
May 16, 2011, Mediterranean Journal of Hematology and Infectious diseases
Study Reveals Origins of a Cancer Affecting the Blood And Bone Marrow
May 12, 2011, Insciences organisation
Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase
May 11, 2011, ScienceDirect
Bcr-Abl Kinase Domain Mutation Analysis in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inihibitors: Recommendations From an Expert Panel on Behalf of European LeukemiaNet
May 11, 2011, Oncology Stat
OHSU, cancer patients celebrate ten years of Gleevec
May 10, 2011, K103FM
Oregon Health & Science University celebrates 10th anniversary of cancer drug Gleevec
May 10, 2011, OregonLive.com
High Dose Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients - Systematic Review and Meta-Analysis
May 9, 2011, Oncology Stat
NICE provisionally rejects leukaemia drugs Sprycel, Tasigna and Glivec
May 6, 2011, Firstword
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
May 5, 2011, Journal of Clinical Oncology
The soul of a cell: Researchers used advanced instrument to read cells' minds
May 5, 2011, Stanford School of Medicine
ARIAD Reports First Quarter 2011 Financial Results and Development Progress
May 4, 2011, Enhanced Online News
A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia.
May 3, 2011, Unbound Medline
CML patients’ dilemma
May 2, 2009, The Star Online
Predicting Complete Cytogenetic Response and Subsequent Progression-Free Survival in 2060 Patients With CML on Imatinib Treatment: The EUTOS Score
May 2, 2011, OncologyStat
Day in the Life: OHSU's Brian Druker
April 29, 2011, Portland Business Journal
US Appeals Court Opens Federal Funding for Stem Cell Research
April 29, 2011, ScienceDaily
Nonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia
April 27, 2011, Wiley Online Library
Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet
April 24, 2011, Journal Blood
A Model of Oscillatory Blood Cell Counts in Chronic Myelogenous Leukaemia.
April 22, 2011, Springerlink.com
An Oncologist's Pulitzer-Winning Cancer Biography
April 22, 2011, Wbur.org
Does Pretreatment Fluorescence In Situ Hybridization for BCR–ABL Predict Imatinib-Associated Hematologic Toxicity in Chronic Myeloid Leukemia?
April 20, 2011, OncologyStat
Decoding Cancer Patients' Genomes Is Powerful Diagnostic Tool
April 20, 2011, ScienceDaily
Considerations in the Management of Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy
April 20, 2011,Journal of Clinical Oncology
The ABL Switch Control Inhibitor DCC-2036 Is Active against the Chronic Myeloid Leukemia Mutant BCR-ABLT315I and Exhibits a Narrow Resistance Profile
April 19, 2011, Unbound Medline
A Triumph in the War Against Cancer
Spring 2011, Smithsonian.com
Updates of New Strategies in Chronic Myelogenous Leukemia
Spring 2011, Leukemia Insights, MD Anderson Cancer Center
A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia
April 14, 2011,Blood Journal
A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia
April 14 2011, Journal Blood
Study: Revolutionary Treatment Returns Normal Life Expectancy to CML Patients
April 12, 2011, EmpowHer
New drug shows potential for treatment-resistant leukemia
April 11, 2011, Pharmalive
Third Rock’s biggest bet ever is on cancer drugs
April 11, 2011, boston.com
Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
April 10, 2011, Journal Blood
ARIAD Presents New Preclinical Data On Ponatinib In Solid Tumors, Demonstrating Inhibition Of All FGF Receptor Kinases
April 6, 2011, Medical News Today
A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
April 1, 2011, PubLmed
The 2011 Stanley J. Korsmeyer Award
April 1, 2011, The American Society for Clinical Investigation
Potential Treatment For Chemotherapy-Resistant Chronic Myeloid Leukaemia
March 31, 2011, Medical News Today
Study Reveals No Impact of Age on Outcome in Chronic Myeloid Leukemia Patients Treated With Imatinib
March 30,2011, The American Society of Hematology (ASH)
New approach to leukemia chemotherapy -- is a cure in sight?
March 30, 2011, ScienceDaily
ARIAD And MolecularMD Announce Collaboration for a Companion Diagnostic Test for The T315I BCR-ABL Mutation in Patients With CML
March 28, 2011, Business Wire
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation
March 25, 2011, PublMed
Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML
March 25, 2011, Wiley online Library
CML Patients Taking Imatinib Have Similar Mortality Rates To People In General Population
March 22, 2011, JNCI Journal of the National Cancer Institute
Leukemia Patients Taking Gleevec Achieve ‘Normal’ Death Rate
March 22, 2011, HealthDay News
Gleevec Gets High Marks for Leukemia Treatment
March 22, 2011, WebMD
Imatinib for Chronic Myeloid Leukemia: The Impact of Its Effectiveness and Long-term Side Effects
March 21, 2011, JNCI Journal of the National Cancer InstituteBone Marrow Transplant Centres Alerted To Help Japan Radiation Victims
March 16, 2011, Medical News Today
Second-Line TKIs Offer Expanded Treatment Options For Newly Diagnosed Patients With CML
March 14, 2011, Medical News Today
Can grapefruit juice decrease the cost of imatinib for the treatment of chronic myelogenous leukemia?
March 7, 2011, Leukemia Research
Discontinuation of imatinib may be possible in chronic myelogenous leukemia
March 3, 2011, Cancer Journal for Clinicians
FDA Warns GERD Drugs May Deplete Magnesium
March 2, 2011, Medpage Today
Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapy;
February 28, 2011, Haematologica
Second-generation drugs called into first-line therapy for CML
February 25, 2011, Hemonctoday
Survival of chronic myeloid leukemia stem cells is independent of BCR-ABL tyrosine kinase activity
February 23, 2011, Oregon Health & Science University (OSHU)
The renaissance of interferon therapy for the treatment of myeloid malignancies
February 22, 2011, Journal Blood
Changing the paradigm in frontline CML therapy VIDEO
Prof Giuseppe Saglio - University of Turin, Italy;
Dr Delphine Rea - Saint Louis Hospital, Paris;
Jan Geissler - Co-Founder, CML Advocates Network
February 21, 2011, ecancer.tv
What`s new in chronic myeloid leukemia research and treatment?
February 17, 2011, American cancer Society
Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study
February 2011, PublMed
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib
February 8, 2011, JNCI Journal of the National Cancer Institute
A single-tube allele specific-polymerase chain reaction to detect T315I resistant mutation in chronic myeloid leukemia patients
February 8, 2011,7th Space Interactive
The Matriarch of Modern Cancer Genetics
February 7, 2011, The New York Times
Clinical value of assessing the response to imatinib monitored by interphase FISH and RQ-PCR for BCR-ABL in peripheral blood for long-term survival of chronic phase CML patients: results of the Niigata CML-multi-institutional co-operative clinical study.
February 5, 2011, PublMed
Scientists reprogram marrow cells from patient with chronic myeloid leukemia
February 4, 2011, The Medicals News
Hematology: Curing CML with imatinib—a dream come true?
February 1, 2011, Nature Reviews Clinical Oncology
World Cancer Day 2011 - A World without Cancer One Day?
February 2011, Dr. Toh Han Chong, National Cancer Center, Singapore
Southampton scientists begin patient trials of new leukemia cancer vaccine
January 31, 2011, Physorg.com
University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
January 31,2011, PharmaLive
Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors.
January 26, 2011, PubLMed
Bosutinib as a treatment for newly diagnosed chronic myeloid leukaemia VIDEO
February 18, 2011, ecancerTV
Fertility in Women Diagnosed with Chronic Myeloid Leukemia
January 18, 2011, Preservation of fertility
Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?
January 17, 2011, Unbound Medline
Cancer: Should we stop trying to cure it?
January 15, 2011, Guardian.co.uk
Effects of imatinib mesylate on the pharmacokinetics of paracetamol (acetaminophen) in Korean patients with chronic myelogenous leukaemia
January 10, 2011, Wiley Online Library
Blood test to spot cancer gets big boost from J&J
January 5,2011, USA.TODAY.com
Time-specific blockade of PDGFR with Imatinib (Glivec) causes cataract and disruption of lens fiber cells in neonatal mice.
December 27, 2010, BipPortfolio
Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
December 23, 2010, The New England Journal of Medicine
Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy.
December 22, 2010, Unbound Medline
Cancer Cells May Be Able to Urge Their Own Death
December 22, 2010, CancerCompass
ASH 2010 Report: A new era in first line CML treatment coming up?
December 15, 2010, CML Advocates Network
Vital Discovery in Leukemia Stem Cell
December 15, 2010, Med India
Chronic Myeloid Leukemia: New Approaches Needed
December 15, 2010, MedicalNewsToday
Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system.
December 15, 2010, CMLHope.com
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
December 13, 2010, The Journal of Clinical Investigation
BCR-ABL kinase is dead; long live the CML stem cell
December 13, 2010, The Journal of Clinical Investigation
Zen Meditation Can Help Bring Pain Under Control
December 10, 2010, HealthDay news
Treatment of the elderly population with haematological cancers: What's new from the American Society of Hematology 2010 meeting?
December 8, 2010, ecancermedicalscience
Industry update: Bosutinib produces molecular response as first-line CML therapy
December 8, 2010, CancerNetwork.com
Deeper molecular responses seen with dasatinib in new chronic myeloid leukemia
December 7, 2010, CancerNetwork.net
Dasatinib moves ahead of imatinib as front-line therapy for newly diagnosed CML in chronic phase
December 7, 2010, CancerNetwork.com
Nilotinib exerts positive effect in early chronic phase Ph+ CML
December 7, 2010, CancerNetwork.com
ASH meeting: Pfizer’s bosutinib disappoints in myeloid leukemia trial; Novartis’ Tasigna beats Glivec in CML study
December 7, 2010, Thepharmaletter
ASH: New CML Drug Still Beating Out Its Predecessor
December 7, 2010, Medpage Today
Persistence of BCR-ABL-Expressing leukemic stem cells in chronic myeloid leukemia (CML) patients in complete remission with undetectable molecular disease
December 7, 2010, ASH 2010
Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy
December 6, 2010, Haematologica
Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia
December 6, 2010, Digital Journal
Compound Bosutinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia
December 6, 2010, Dagorret
ASH: Early assessment of molecular response identified increased risk for treatment failure in CML
December 6, 2010, Hemonctoday
Novel CML Drug Active After Failures of Imatinib, Dasatinib, and Nilotinib
December 6, 2010, Oncology Stat
ASH 2010: JAK2-Mediated Extrinsic Survival of CML Stem Cells: Exploring the Potential Combination of BCR-ABL and JAK2 Inhibitors In Vivo
December 6, 2010, ASH2010
Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia
December 5, 2010, ASH2010
Provocative Questions For CML Patients and Their Doctors (With Dr. M. Talpaz) VIDEO
December 5, 2010, Patient Power , ASH 2010, Orlando
Do 3rd Generation Medicines Lie Ahead for CML? (with Dr. Neil Shah ) VIDEO
December 4, 2010, Patient Power , ASH 2010, Orlando
Progress in Chronic Leukemias (with Dr. Alison Loren) VIDEO
December 4, 2010, Patient Power , ASH 2010, Orlando
ASH 2010: Ponatinib for refractory chronic myelogenous leukaemia
December 4, 2010, EcancerMedicalScience
ASH 2010: Nilotinib promising for early chronic phase, Philidelphia-positive chronic myeloid leukaemia
December 4, 2010, Ecancermedicalscience
Pfizer Plans Regulatory Submissions Of Bosutinib In Chronic Myeloid Leukemia
December 4, 2010, Medical NewsToday
Nilotinib associated with stable outcomes in Ph+CML
December 4, 2010, Hemonctoday
Breakthrough Therapies and a New Gene Target Advance the Treatment and Understanding of Hard-to-Treat Leukemias
December 4, 2010, Hematology.org
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
December 4, 2010, Hematology
Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase
December 2, 2010, Dovepress
Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
November 29, 2010, PubLMed
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
November 26, 2010, 7th Space
CML—The Changing Landscape of Front-line Therapy: Part I: Interview With Dr. Jane Apperley
November 23, 2010, OncologyStat - CMLSupport
Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia
November 19, 2010, Leukemia
Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission
November 18, 2010, BMC Blood Disorders
Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms
November 16, 2010, SciElO Brazil
Mutated Gene Linked to Poor Survival in Acute Myeloid Leukemia
November 16, 2010, National Cancer Institute
Nilotinib Attenuates Renal Injury and Prolongs Survival in Chronic Kidney Disease
November 13, 2010, JASN
Low Vitamin D Linked to Deterioration in Certain Leukemia Patients
November 12, 2010, MedecineNet.com
Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemia.
November 9, 2010, PubLMed
Leukemia breakthrough suggested in lab finding
November 7, 2010, Globe and Mail
Canadian researchers transform skin into blood
November 7,2010, National Post
FDA Approves SPRYCEL (dasatinib) as Treatment for Adult Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia
October 28, 2010,FierceBiotech
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR.
October 24, 2010,PubLMed
Nurse Practitioner Carolyn Blasdel – Montreal – August 2010 VIDEO
October 2010, CML Society of Canada
Stem Cell Transplants Available to Expanding Group of Patients
October 2010, PatientPower.info
An Evening with the CML Experts™ featuring Dr. Michael Mauro - Phoenix, Arizona VIDEO
October 2010,
The National CML Society Could Some Patients Stop Taking Their CML Pills?
October 2010, Patient Power
Dr. Georges Mathé, Transplant Pioneer, Dies at 88
October 2010, New York Times
CML: The Current Landscape - an interview with Dr. Jorge Cortes VIDEO
October 2010, The National CML Society (US)
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
October 2010, The Lancet Oncology, Early Online Publication
Some With Once-Deadly Leukemia Can Take a Break From GleevecSmall minority of CML patients went off the drug for 2 years with no sign of recurrence
October 2010, Healthday, U.S. News
CML Society of Canada - CML Awareness Day celebrates great progress against blood cancer but much more needed to ensure best outcomes for Canadian patients
September 2010, CNW Group
Philadelphia chromosome’ led to breakthrough in cancer treatment
September 2010, Philadelphia Business Journal
Do we have to kill the last CML cell?
September 2010, Nature.com
Dr. Sawyers on Outsmarting Cancer VIDEO
Dr. Charles Sawyers tells Katie Couric about the difficulties in treating different kinds of cancers, and importance of drug cocktails
September 2010, CBSNEWS.com
50th Anniversary of the Discovery of the Philadelphia Chromosome
September 28, 2010, WorldNews
Leukemia Types, Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML)
10 sept 2010, Healthcommunities.com
Fox Chase Celebrates the 50th Anniversary of the Discovery of the Philadelphia Chromosome
August 23, 2010, Fox Chase Center
Technique to Preserve Fertility in Young Women May Be Unsafe for Patients With Leukemia
August 16, 2010, Science Daily
Living with chronic myeloid leukemia VIDEO
Chronic myeloid leukemia, or CML, was once considered a death sentence but new treatment options have turned CML into a chronic, yet manageable disease for most patients.August 2010,Info4YourLifeDrug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib
August 2010, Journal Blood
A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib
August 2010, Leukemia Research
Dasatinib, an immunomodulator?
August 2010, Journal Blood
New lab test could identify imatinib resistance
July 2010, Sciences News
Protein That Predicts Prognosis of Leukemia Patients May Also Be a Therapeutic Target
July 10, 2010, Science Daily
Chronic myeloid leukemia: mechanisms of blastic transformation
July 1, 2010, The Journal of Clinical Investigation
Novartis gets US FDA approval for new Tasigna indication; agency panel backs HRA Pharma's ulipristal
June 18, 2010, Thepharmaletter
Cord blood transplants a viable option in leukemia
June 15, 2010, Reuters
Newer Drugs Improve Upon Gleevec for Chronic Myeloid Leukemia VIDEO
June 04, 2010, MD Anderson Cancer Center
Update on Tyrosine Kinase Inhibitor Therapy for Chronic ...
June 2010, ASHP Advantage
Benefits of Banking Cord Blood
May 10, 2010, Suite101
PCR Confusion – A CML Patient’s Perspective
May 18, 2010, Cancernetwork.com
Differing age patterns in chronic myeloid leukemia by racial ethnic group.
May 2010, Journal of Clinical Oncology
South Korean firm develops drug to kill leukemia stem cells
April 22, 2010, BioSpectrum
Combination of simvastatin and imatinib sensitizes the CD34+ cells in K562 to cell death
March 31, 2010, Mendeley
BioSante announce positive data from GVAX leukemia vaccine in CML
March 2010, Pharma Strategy Blog
High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study.
February 2010, PubLMed
Living With a Formerly Fatal Blood Cancer
January 2010, The New York Times
Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy
January 9, 2010,
June 30, 2011, Oncology Stat
Lincoln Leukaemia patient protests cancer funds withdrawal
June 30, 2011, Lincolnshire
Using the Web to understand your medical condition
June 29, 2011, Komonews.com
Inovio Pharmaceuticals' Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
June 29, 2011, PrNewswire
Tasigna receives Canadian approval
June 27, 2011, CNW
The Latest Weapon Against Cancer: Evolution
June 25, 2011, The Wall Street Journal
A message from a mending heart
June 25, 2011, Dayton Daily News
Bill Would Ensure Patient Access to Oral Chemotherapies
June 23, 2011, wgrz.com
Ph: not bad at all
June 22, 2011, Journal Blood
Evaluation of BCR-ABL monitoring in Chronic Myelogenous Leukemia in clinical practice VIDEO
June 21, 2011, OncUViewTV
Is There a Virus-Versus-Leukemia Effect?
June 21, 2011, CancerNetwork
Health groups want accessible drugs
June 21, 2011, WWLP.com
Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML
June 21, 2011, Journal Blood
Imatinib sensitivity in BCR-ABL1-positive chronic myeloid leukemia cells is regulated by the remaining normal ABL1 allele
June 21, 2011, Cancer Research
Nilotinib Beats Imatinib at 24 Months in Treatment of CML
June 20, 2011, MedscapeToday
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
June 20, 2011, Journal of Clinical Oncology
Cancer survivors beat the odds, graduate high school VIDEO
June 20, 2011, MSNBC.com
Ariad Pharma - Ahead Of PACE
June 17, 2011, RTTNews
Race brings out the best in survivors
June 17, 2011, adn.com
Faster Response Rates in CML with Bosutinib
June 15, 2011, MedscapeToday
The ghost of personalized medicine
June 14, 2011, The Scientist
Towards a more efficient therapy for a specific form of leukemia
June 14, 2011, AlphaGalileo
Webcasts of EHA Education Sessions are well worth watching
June 14, 2011, Biotech Strategy Blog
Treatment of chronic phase (CP) chronic myeloid leukemia (CML) patients who harbour the BCR-ABL T315I mutation with subcutaneous omacetaxine results in improved survival compared to historical data
June 12 2011, EHA 2011
Cessation of dasatinib or nilotinib therapy in chronic- phase chronic myeloid leukaemia patients with sustained complete molecular responses
June 12, 2011, EHA 2011
CML patients treated with TKI’s who obtain major molecular response are highly protected for transformation and this protection seems to be independent of the 18-month cutoff
June 11, 2011, EHA 2011
A molecular criteria have now been defined to guide decisions about if and when to use dasatinib or nilotinib VIDEO
June 11, 2011, ecancecr,tv
1 of the girls
June 9, 2011, dallasvoice.com
Leukaemia patients protest in Manchester at drugs threat
June 9, 2011, BBC - News Manchester
Cancer survivor: Tell people what you're going through
June 9, 2011, Rapid City Journal
Nilotinib Superior to Imatinib, Fewer Mutations in Treatment of CML-CP
June 6, 2011, Monthly Prescribing Reference
Improved survival in chronic myeloid leukemia (CML) since introduction of imatinib therapy: A single-institution experience in 1,570 patients referred within 1 month from diagnosis
June 6, 2011, ASCO 2011
A new symptom measure in chronic myeloid leukemia
June 6, 2011, ASCO 2011
Not his best time, but 'best' race for veteran runner
June 5, 2011, Sign on San Diego
Bosutinib Achieves Faster Response Rates in Newly Diagnosed Chronic Phase CML Patients Than Imatinib
June 3 , 2011, Monthly Prescribing Reference
Dasatinib Shows Superior Efficacy and Acceptable Tolerability, Supporting First-Line Use in Newly Diagnosed CML-CP
June 3 , 2011, Monthly Prescribing Reference
Leukemia drug tied to impaired growth in kids
June 2, 2011, Caring4Cancer
What can nurses do to help cancer survivors?
May 31, 2011, NursingTimes.com
Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis
May 31, 2011, PubLmed
Reframing our thinking about cancer
May 26, 2011, Benefits Canada
Developer of Gleevec sees potential for more cancer drugs, will speak at Moffitt Cancer Center
May 26, 2011, tampabay.com
New Protein Linked to Alzheimer's Disease
May 25, 2011, Science Daily
Understanding Targeted Treatments
May 25, 2011, Cancer.net
Children’s Hospital Los Angeles Team Discovers Key to Fighting Drug-Resistant Leukemia
May 18, 2011, Enhanced Online News
Improved Survival And Treatment For Chronic Blood Disorders
May 18, 2011, Medical News Today
New approach to overcoming TKI resistance
May 18, 2001, ecancermedicalnews
Low incidence rate of opportunistic and viral infections during imatinib
treatment in chronic myeloid leukemia patients in early and late chronic phase
May 16, 2011, Mediterranean Journal of Hematology and Infectious diseases
Study Reveals Origins of a Cancer Affecting the Blood And Bone Marrow
May 12, 2011, Insciences organisation
Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase
May 11, 2011, ScienceDirect
Bcr-Abl Kinase Domain Mutation Analysis in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inihibitors: Recommendations From an Expert Panel on Behalf of European LeukemiaNet
May 11, 2011, Oncology Stat
OHSU, cancer patients celebrate ten years of Gleevec
May 10, 2011, K103FM
Oregon Health & Science University celebrates 10th anniversary of cancer drug Gleevec
May 10, 2011, OregonLive.com
High Dose Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients - Systematic Review and Meta-Analysis
May 9, 2011, Oncology Stat
NICE provisionally rejects leukaemia drugs Sprycel, Tasigna and Glivec
May 6, 2011, Firstword
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
May 5, 2011, Journal of Clinical Oncology
The soul of a cell: Researchers used advanced instrument to read cells' minds
May 5, 2011, Stanford School of Medicine
ARIAD Reports First Quarter 2011 Financial Results and Development Progress
May 4, 2011, Enhanced Online News
A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia.
May 3, 2011, Unbound Medline
CML patients’ dilemma
May 2, 2009, The Star Online
Predicting Complete Cytogenetic Response and Subsequent Progression-Free Survival in 2060 Patients With CML on Imatinib Treatment: The EUTOS Score
May 2, 2011, OncologyStat
Day in the Life: OHSU's Brian Druker
April 29, 2011, Portland Business Journal
US Appeals Court Opens Federal Funding for Stem Cell Research
April 29, 2011, ScienceDaily
Nonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia
April 27, 2011, Wiley Online Library
Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet
April 24, 2011, Journal Blood
A Model of Oscillatory Blood Cell Counts in Chronic Myelogenous Leukaemia.
April 22, 2011, Springerlink.com
An Oncologist's Pulitzer-Winning Cancer Biography
April 22, 2011, Wbur.org
Does Pretreatment Fluorescence In Situ Hybridization for BCR–ABL Predict Imatinib-Associated Hematologic Toxicity in Chronic Myeloid Leukemia?
April 20, 2011, OncologyStat
Decoding Cancer Patients' Genomes Is Powerful Diagnostic Tool
April 20, 2011, ScienceDaily
Considerations in the Management of Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy
April 20, 2011,Journal of Clinical Oncology
The ABL Switch Control Inhibitor DCC-2036 Is Active against the Chronic Myeloid Leukemia Mutant BCR-ABLT315I and Exhibits a Narrow Resistance Profile
April 19, 2011, Unbound Medline
A Triumph in the War Against Cancer
Spring 2011, Smithsonian.com
Updates of New Strategies in Chronic Myelogenous Leukemia
Spring 2011, Leukemia Insights, MD Anderson Cancer Center
A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia
April 14, 2011,Blood Journal
A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia
April 14 2011, Journal Blood
Study: Revolutionary Treatment Returns Normal Life Expectancy to CML Patients
April 12, 2011, EmpowHer
New drug shows potential for treatment-resistant leukemia
April 11, 2011, Pharmalive
Third Rock’s biggest bet ever is on cancer drugs
April 11, 2011, boston.com
Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
April 10, 2011, Journal Blood
ARIAD Presents New Preclinical Data On Ponatinib In Solid Tumors, Demonstrating Inhibition Of All FGF Receptor Kinases
April 6, 2011, Medical News Today
A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
April 1, 2011, PubLmed
The 2011 Stanley J. Korsmeyer Award
April 1, 2011, The American Society for Clinical Investigation
Potential Treatment For Chemotherapy-Resistant Chronic Myeloid Leukaemia
March 31, 2011, Medical News Today
Study Reveals No Impact of Age on Outcome in Chronic Myeloid Leukemia Patients Treated With Imatinib
March 30,2011, The American Society of Hematology (ASH)
New approach to leukemia chemotherapy -- is a cure in sight?
March 30, 2011, ScienceDaily
ARIAD And MolecularMD Announce Collaboration for a Companion Diagnostic Test for The T315I BCR-ABL Mutation in Patients With CML
March 28, 2011, Business Wire
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation
March 25, 2011, PublMed
Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML
March 25, 2011, Wiley online Library
CML Patients Taking Imatinib Have Similar Mortality Rates To People In General Population
March 22, 2011, JNCI Journal of the National Cancer Institute
Leukemia Patients Taking Gleevec Achieve ‘Normal’ Death Rate
March 22, 2011, HealthDay News
Gleevec Gets High Marks for Leukemia Treatment
March 22, 2011, WebMD
Imatinib for Chronic Myeloid Leukemia: The Impact of Its Effectiveness and Long-term Side Effects
March 21, 2011, JNCI Journal of the National Cancer InstituteBone Marrow Transplant Centres Alerted To Help Japan Radiation Victims
March 16, 2011, Medical News Today
Second-Line TKIs Offer Expanded Treatment Options For Newly Diagnosed Patients With CML
March 14, 2011, Medical News Today
Can grapefruit juice decrease the cost of imatinib for the treatment of chronic myelogenous leukemia?
March 7, 2011, Leukemia Research
Discontinuation of imatinib may be possible in chronic myelogenous leukemia
March 3, 2011, Cancer Journal for Clinicians
FDA Warns GERD Drugs May Deplete Magnesium
March 2, 2011, Medpage Today
Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapy;
February 28, 2011, Haematologica
Second-generation drugs called into first-line therapy for CML
February 25, 2011, Hemonctoday
Survival of chronic myeloid leukemia stem cells is independent of BCR-ABL tyrosine kinase activity
February 23, 2011, Oregon Health & Science University (OSHU)
The renaissance of interferon therapy for the treatment of myeloid malignancies
February 22, 2011, Journal Blood
Changing the paradigm in frontline CML therapy VIDEO
Prof Giuseppe Saglio - University of Turin, Italy;
Dr Delphine Rea - Saint Louis Hospital, Paris;
Jan Geissler - Co-Founder, CML Advocates Network
February 21, 2011, ecancer.tv
What`s new in chronic myeloid leukemia research and treatment?
February 17, 2011, American cancer Society
Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study
February 2011, PublMed
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib
February 8, 2011, JNCI Journal of the National Cancer Institute
A single-tube allele specific-polymerase chain reaction to detect T315I resistant mutation in chronic myeloid leukemia patients
February 8, 2011,7th Space Interactive
The Matriarch of Modern Cancer Genetics
February 7, 2011, The New York Times
Clinical value of assessing the response to imatinib monitored by interphase FISH and RQ-PCR for BCR-ABL in peripheral blood for long-term survival of chronic phase CML patients: results of the Niigata CML-multi-institutional co-operative clinical study.
February 5, 2011, PublMed
Scientists reprogram marrow cells from patient with chronic myeloid leukemia
February 4, 2011, The Medicals News
Hematology: Curing CML with imatinib—a dream come true?
February 1, 2011, Nature Reviews Clinical Oncology
World Cancer Day 2011 - A World without Cancer One Day?
February 2011, Dr. Toh Han Chong, National Cancer Center, Singapore
Southampton scientists begin patient trials of new leukemia cancer vaccine
January 31, 2011, Physorg.com
University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
January 31,2011, PharmaLive
Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors.
January 26, 2011, PubLMed
Bosutinib as a treatment for newly diagnosed chronic myeloid leukaemia VIDEO
February 18, 2011, ecancerTV
Fertility in Women Diagnosed with Chronic Myeloid Leukemia
January 18, 2011, Preservation of fertility
Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?
January 17, 2011, Unbound Medline
Cancer: Should we stop trying to cure it?
January 15, 2011, Guardian.co.uk
Effects of imatinib mesylate on the pharmacokinetics of paracetamol (acetaminophen) in Korean patients with chronic myelogenous leukaemia
January 10, 2011, Wiley Online Library
Blood test to spot cancer gets big boost from J&J
January 5,2011, USA.TODAY.com
Time-specific blockade of PDGFR with Imatinib (Glivec) causes cataract and disruption of lens fiber cells in neonatal mice.
December 27, 2010, BipPortfolio
Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
December 23, 2010, The New England Journal of Medicine
Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy.
December 22, 2010, Unbound Medline
Cancer Cells May Be Able to Urge Their Own Death
December 22, 2010, CancerCompass
ASH 2010 Report: A new era in first line CML treatment coming up?
December 15, 2010, CML Advocates Network
Vital Discovery in Leukemia Stem Cell
December 15, 2010, Med India
Chronic Myeloid Leukemia: New Approaches Needed
December 15, 2010, MedicalNewsToday
Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system.
December 15, 2010, CMLHope.com
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
December 13, 2010, The Journal of Clinical Investigation
BCR-ABL kinase is dead; long live the CML stem cell
December 13, 2010, The Journal of Clinical Investigation
Zen Meditation Can Help Bring Pain Under Control
December 10, 2010, HealthDay news
Treatment of the elderly population with haematological cancers: What's new from the American Society of Hematology 2010 meeting?
December 8, 2010, ecancermedicalscience
Industry update: Bosutinib produces molecular response as first-line CML therapy
December 8, 2010, CancerNetwork.com
Deeper molecular responses seen with dasatinib in new chronic myeloid leukemia
December 7, 2010, CancerNetwork.net
Dasatinib moves ahead of imatinib as front-line therapy for newly diagnosed CML in chronic phase
December 7, 2010, CancerNetwork.com
Nilotinib exerts positive effect in early chronic phase Ph+ CML
December 7, 2010, CancerNetwork.com
ASH meeting: Pfizer’s bosutinib disappoints in myeloid leukemia trial; Novartis’ Tasigna beats Glivec in CML study
December 7, 2010, Thepharmaletter
ASH: New CML Drug Still Beating Out Its Predecessor
December 7, 2010, Medpage Today
Persistence of BCR-ABL-Expressing leukemic stem cells in chronic myeloid leukemia (CML) patients in complete remission with undetectable molecular disease
December 7, 2010, ASH 2010
Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy
December 6, 2010, Haematologica
Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia
December 6, 2010, Digital Journal
Compound Bosutinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia
December 6, 2010, Dagorret
ASH: Early assessment of molecular response identified increased risk for treatment failure in CML
December 6, 2010, Hemonctoday
Novel CML Drug Active After Failures of Imatinib, Dasatinib, and Nilotinib
December 6, 2010, Oncology Stat
ASH 2010: JAK2-Mediated Extrinsic Survival of CML Stem Cells: Exploring the Potential Combination of BCR-ABL and JAK2 Inhibitors In Vivo
December 6, 2010, ASH2010
Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia
December 5, 2010, ASH2010
Provocative Questions For CML Patients and Their Doctors (With Dr. M. Talpaz) VIDEO
December 5, 2010, Patient Power , ASH 2010, Orlando
Do 3rd Generation Medicines Lie Ahead for CML? (with Dr. Neil Shah ) VIDEO
December 4, 2010, Patient Power , ASH 2010, Orlando
Progress in Chronic Leukemias (with Dr. Alison Loren) VIDEO
December 4, 2010, Patient Power , ASH 2010, Orlando
ASH 2010: Ponatinib for refractory chronic myelogenous leukaemia
December 4, 2010, EcancerMedicalScience
ASH 2010: Nilotinib promising for early chronic phase, Philidelphia-positive chronic myeloid leukaemia
December 4, 2010, Ecancermedicalscience
Pfizer Plans Regulatory Submissions Of Bosutinib In Chronic Myeloid Leukemia
December 4, 2010, Medical NewsToday
Nilotinib associated with stable outcomes in Ph+CML
December 4, 2010, Hemonctoday
Breakthrough Therapies and a New Gene Target Advance the Treatment and Understanding of Hard-to-Treat Leukemias
December 4, 2010, Hematology.org
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
December 4, 2010, Hematology
Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase
December 2, 2010, Dovepress
Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
November 29, 2010, PubLMed
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
November 26, 2010, 7th Space
CML—The Changing Landscape of Front-line Therapy: Part I: Interview With Dr. Jane Apperley
November 23, 2010, OncologyStat - CMLSupport
Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia
November 19, 2010, Leukemia
Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission
November 18, 2010, BMC Blood Disorders
Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms
November 16, 2010, SciElO Brazil
Mutated Gene Linked to Poor Survival in Acute Myeloid Leukemia
November 16, 2010, National Cancer Institute
Nilotinib Attenuates Renal Injury and Prolongs Survival in Chronic Kidney Disease
November 13, 2010, JASN
Low Vitamin D Linked to Deterioration in Certain Leukemia Patients
November 12, 2010, MedecineNet.com
Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemia.
November 9, 2010, PubLMed
Leukemia breakthrough suggested in lab finding
November 7, 2010, Globe and Mail
Canadian researchers transform skin into blood
November 7,2010, National Post
FDA Approves SPRYCEL (dasatinib) as Treatment for Adult Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia
October 28, 2010,FierceBiotech
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR.
October 24, 2010,PubLMed
Nurse Practitioner Carolyn Blasdel – Montreal – August 2010 VIDEO
October 2010, CML Society of Canada
Stem Cell Transplants Available to Expanding Group of Patients
October 2010, PatientPower.info
An Evening with the CML Experts™ featuring Dr. Michael Mauro - Phoenix, Arizona VIDEO
October 2010,
The National CML Society Could Some Patients Stop Taking Their CML Pills?
October 2010, Patient Power
Dr. Georges Mathé, Transplant Pioneer, Dies at 88
October 2010, New York Times
CML: The Current Landscape - an interview with Dr. Jorge Cortes VIDEO
October 2010, The National CML Society (US)
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
October 2010, The Lancet Oncology, Early Online Publication
Some With Once-Deadly Leukemia Can Take a Break From GleevecSmall minority of CML patients went off the drug for 2 years with no sign of recurrence
October 2010, Healthday, U.S. News
CML Society of Canada - CML Awareness Day celebrates great progress against blood cancer but much more needed to ensure best outcomes for Canadian patients
September 2010, CNW Group
Philadelphia chromosome’ led to breakthrough in cancer treatment
September 2010, Philadelphia Business Journal
Do we have to kill the last CML cell?
September 2010, Nature.com
Dr. Sawyers on Outsmarting Cancer VIDEO
Dr. Charles Sawyers tells Katie Couric about the difficulties in treating different kinds of cancers, and importance of drug cocktails
September 2010, CBSNEWS.com
50th Anniversary of the Discovery of the Philadelphia Chromosome
September 28, 2010, WorldNews
Leukemia Types, Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML)
10 sept 2010, Healthcommunities.com
Fox Chase Celebrates the 50th Anniversary of the Discovery of the Philadelphia Chromosome
August 23, 2010, Fox Chase Center
Technique to Preserve Fertility in Young Women May Be Unsafe for Patients With Leukemia
August 16, 2010, Science Daily
Living with chronic myeloid leukemia VIDEO
Chronic myeloid leukemia, or CML, was once considered a death sentence but new treatment options have turned CML into a chronic, yet manageable disease for most patients.August 2010,Info4YourLifeDrug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib
August 2010, Journal Blood
A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib
August 2010, Leukemia Research
Dasatinib, an immunomodulator?
August 2010, Journal Blood
New lab test could identify imatinib resistance
July 2010, Sciences News
Protein That Predicts Prognosis of Leukemia Patients May Also Be a Therapeutic Target
July 10, 2010, Science Daily
Chronic myeloid leukemia: mechanisms of blastic transformation
July 1, 2010, The Journal of Clinical Investigation
Novartis gets US FDA approval for new Tasigna indication; agency panel backs HRA Pharma's ulipristal
June 18, 2010, Thepharmaletter
Cord blood transplants a viable option in leukemia
June 15, 2010, Reuters
Newer Drugs Improve Upon Gleevec for Chronic Myeloid Leukemia VIDEO
June 04, 2010, MD Anderson Cancer Center
Update on Tyrosine Kinase Inhibitor Therapy for Chronic ...
June 2010, ASHP Advantage
Benefits of Banking Cord Blood
May 10, 2010, Suite101
PCR Confusion – A CML Patient’s Perspective
May 18, 2010, Cancernetwork.com
Differing age patterns in chronic myeloid leukemia by racial ethnic group.
May 2010, Journal of Clinical Oncology
South Korean firm develops drug to kill leukemia stem cells
April 22, 2010, BioSpectrum
Combination of simvastatin and imatinib sensitizes the CD34+ cells in K562 to cell death
March 31, 2010, Mendeley
BioSante announce positive data from GVAX leukemia vaccine in CML
March 2010, Pharma Strategy Blog
High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study.
February 2010, PubLMed
Living With a Formerly Fatal Blood Cancer
January 2010, The New York Times
Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy
January 9, 2010,
Hindawi Publishing CorporationPrevalence of Large Granular Lymphocyte Proliferation in Chronic Myeloid Leukemia (CML) Patients Treated with Dasatinib
December 5, 2009, ASH 2009
Individual Telomere Lengths in Chronic Myeloid Leukemia
November 2009, Neoplasia
Adelaide researchers on road to myeloid leukemia cure
October 2009, NEWS.COM.AU
Emergence of Chronic Myelogenous Leukemia From a Background of Myeloproliferative Disorder: JAK2V617F as a Potential Risk Factor for BCR-ABL Translocation
October 2009, Clinical Lymphoma, Myeloma & Leukemia
Update of recent studies in chronic myeloid leukemia
June 26, 2009, Journal of hematology & oncology
A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment
June 2009, Wiley Online Library
Stanford researchers harness nanoparticles to track cancer cell changes
April 14, 2009, Stanford School of Medicine
Chronic Myeloid Leukemia Therapy: Focus on Second Generation ...
April 2009, moffitt.org
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy
March 2009, Blood Journal
Data suggesting that omacetaxine can eradicate leukemic stem cells may offer a breakthrough for CML
March 26, 2009, eurekalert.org
Scientists Identify Molecular Signature for Leukemia Stem Cells
March 10, 2009, e! Science News
Scientists uncover indicator that warns leukemia is progressing to more dangerous form
February 17,2009, e! Science News
December 5, 2009, ASH 2009
Individual Telomere Lengths in Chronic Myeloid Leukemia
November 2009, Neoplasia
Adelaide researchers on road to myeloid leukemia cure
October 2009, NEWS.COM.AU
Emergence of Chronic Myelogenous Leukemia From a Background of Myeloproliferative Disorder: JAK2V617F as a Potential Risk Factor for BCR-ABL Translocation
October 2009, Clinical Lymphoma, Myeloma & Leukemia
Update of recent studies in chronic myeloid leukemia
June 26, 2009, Journal of hematology & oncology
A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment
June 2009, Wiley Online Library
Stanford researchers harness nanoparticles to track cancer cell changes
April 14, 2009, Stanford School of Medicine
Chronic Myeloid Leukemia Therapy: Focus on Second Generation ...
April 2009, moffitt.org
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy
March 2009, Blood Journal
Data suggesting that omacetaxine can eradicate leukemic stem cells may offer a breakthrough for CML
March 26, 2009, eurekalert.org
Scientists Identify Molecular Signature for Leukemia Stem Cells
March 10, 2009, e! Science News
Scientists uncover indicator that warns leukemia is progressing to more dangerous form
February 17,2009, e! Science News
Cancer drugs may treat type 1 diabetes
November 11, 2008, Bio-Medecine
New Stanford diagnostic test for rare leukemia appears to give faster results, study finds
October 6, 2008, Stanford School of Medicine
Targeted therapies for CML: practical considerations and comparisons
August 10, 2008, HemOncToday
Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib
March 2006, Journal of Clinical Oncology
November 11, 2008, Bio-Medecine
New Stanford diagnostic test for rare leukemia appears to give faster results, study finds
October 6, 2008, Stanford School of Medicine
Targeted therapies for CML: practical considerations and comparisons
August 10, 2008, HemOncToday
Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib
March 2006, Journal of Clinical Oncology
Hypertriglyceridemia may be severe in CML patients treated with interferon-α
July 11, 2006, Wiley Online Library
Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib
March 2006, Journal of Clinical Oncology
July 11, 2006, Wiley Online Library
Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib
March 2006, Journal of Clinical Oncology
